{"entity":"medtronic","name":"Medtronic plc","kind":null,"summary":"Medtronic plc's timeline holds 363 claims from 2012 to 2026: 2 people, 351 money & deals, 10 other. 7 are undated. The latest took effect on August 28, 2026.","counts":{"total":363,"by_kind":{"people":2,"money":351,"products":0,"models":0,"other":10}},"events":[{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc sic industry: Electromedical & Electrotherapeutic Apparatus (3845)\", undated. Claim clm_0203B37C9600, https://asof.is/claim/clm_0203B37C9600, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001613103.","url":"https://asof.is/claim/clm_0203B37C9600","accessed":"2026-11-09"},"kind":"other","predicate":"sic_industry","value":"Electromedical & Electrotherapeutic Apparatus (3845)","status":"valid","assertable":true,"id":"clm_0203B37C9600","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc ticker: MDT\", undated. Claim clm_2353BF9A0F03, https://asof.is/claim/clm_2353BF9A0F03, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001613103.","url":"https://asof.is/claim/clm_2353BF9A0F03","accessed":"2026-11-09"},"kind":"other","predicate":"ticker","value":"MDT","status":"valid","assertable":true,"id":"clm_2353BF9A0F03","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cik: 0001613103\", undated. Claim clm_5B211896C6C4, https://asof.is/claim/clm_5B211896C6C4, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001613103.","url":"https://asof.is/claim/clm_5B211896C6C4","accessed":"2026-11-09"},"kind":"other","predicate":"cik","value":"0001613103","status":"valid","assertable":true,"id":"clm_5B211896C6C4","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc headquarters: Galway\", undated. Claim clm_6145B4A4C1A3, https://asof.is/claim/clm_6145B4A4C1A3, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001613103.","url":"https://asof.is/claim/clm_6145B4A4C1A3","accessed":"2026-11-09"},"kind":"other","predicate":"headquarters","value":"Galway","status":"valid","assertable":true,"id":"clm_6145B4A4C1A3","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc fiscal year end: 04-24\", undated. Claim clm_7F2C5D64900C, https://asof.is/claim/clm_7F2C5D64900C, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001613103.","url":"https://asof.is/claim/clm_7F2C5D64900C","accessed":"2026-11-09"},"kind":"other","predicate":"fiscal_year_end","value":"04-24","status":"valid","assertable":true,"id":"clm_7F2C5D64900C","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc listed on: NYSE\", undated. Claim clm_8CA22BF10A16, https://asof.is/claim/clm_8CA22BF10A16, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001613103.","url":"https://asof.is/claim/clm_8CA22BF10A16","accessed":"2026-11-09"},"kind":"other","predicate":"listed_on","value":"NYSE","status":"valid","assertable":true,"id":"clm_8CA22BF10A16","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc website: https://www.medtronic.com/\", undated. Claim clm_7A9C5D3C3DBA, https://asof.is/claim/clm_7A9C5D3C3DBA, accessed 2026-11-09. Source: https://www.wikidata.org/wiki/Q642189.","url":"https://asof.is/claim/clm_7A9C5D3C3DBA","accessed":"2026-11-09"},"kind":"other","predicate":"website","value":"https://www.medtronic.com/","status":"unverified","assertable":false,"why_not":"low_confidence","id":"clm_7A9C5D3C3DBA","evidence":{"by":"own-site","on":"2026-11-08","quote":"Health tech for the digital age | Medtronic.","url":"https://www.medtronic.com/en-us/index.html"}},{"date":"2012-04-27","until":"2013-04-26","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,172,000,000 United States dollar\", as of 2012-04-27 (until 2013-04-26). Claim clm_B9592B812804, https://asof.is/claim/clm_B9592B812804, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_B9592B812804","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,172,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B9592B812804","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2015-06-23"}},{"date":"2012-04-27","until":"2013-04-26","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 17,113,000,000 United States dollar\", as of 2012-04-27 (until 2013-04-26). Claim clm_CE404E6A8429, https://asof.is/claim/clm_CE404E6A8429, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_CE404E6A8429","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"17,113,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CE404E6A8429","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2015-06-23"}},{"date":"2013-04-26","until":"2014-04-25","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 4,402,000,000 United States dollar\", as of 2013-04-26 (until 2014-04-25). Claim clm_136360BFF25F, https://asof.is/claim/clm_136360BFF25F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_136360BFF25F","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"4,402,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_136360BFF25F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2015, filed 2015-06-23"}},{"date":"2013-04-26","until":"2014-04-25","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 16,590,000,000 United States dollar\", as of 2013-04-26 (until 2014-04-25). Claim clm_26A7D574D1E1, https://asof.is/claim/clm_26A7D574D1E1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_26A7D574D1E1","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"16,590,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_26A7D574D1E1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2015, filed 2015-06-23"}},{"date":"2013-04-26","until":"2014-04-25","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 919,000,000 United States dollar\", as of 2013-04-26 (until 2014-04-25). Claim clm_4A48F87DA5A3, https://asof.is/claim/clm_4A48F87DA5A3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_4A48F87DA5A3","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"919,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4A48F87DA5A3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2015-06-23"}},{"date":"2013-04-26","until":"2014-04-25","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 3,467,000,000 United States dollar\", as of 2013-04-26 (until 2014-04-25). Claim clm_EE6C4061D46C, https://asof.is/claim/clm_EE6C4061D46C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_EE6C4061D46C","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"3,467,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EE6C4061D46C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2015, filed 2015-06-23"}},{"date":"2013-04-26","until":"2014-04-25","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 18,671,000,000 United States dollar\", as of 2013-04-26 (until 2014-04-25). Claim clm_FC6C94C53C26, https://asof.is/claim/clm_FC6C94C53C26, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_FC6C94C53C26","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"18,671,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FC6C94C53C26","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2015-06-23"}},{"date":"2014-04-25","until":"2014-06-12","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,403,000,000 United States dollar\", as of 2014-04-25 (until 2014-06-12). Claim clm_04651C051AA3, https://asof.is/claim/clm_04651C051AA3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_04651C051AA3","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,403,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_04651C051AA3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2015-06-23"}},{"date":"2014-04-25","until":"2015-04-24","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 3,065,000,000 United States dollar\", as of 2014-04-25 (until 2015-04-24). Claim clm_133074D0555D, https://asof.is/claim/clm_133074D0555D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_133074D0555D","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"3,065,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_133074D0555D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2015, filed 2015-06-23"}},{"date":"2014-04-25","until":"2015-04-24","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 17,005,000,000 United States dollar\", as of 2014-04-25 (until 2015-04-24). Claim clm_2AFFCF87BF30, https://asof.is/claim/clm_2AFFCF87BF30, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_2AFFCF87BF30","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"17,005,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2AFFCF87BF30","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2015, filed 2015-06-23"}},{"date":"2014-04-25","until":"2015-01-23","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 19,443,000,000 United States dollar\", as of 2014-04-25 (until 2015-01-23). Claim clm_93F79245FB43, https://asof.is/claim/clm_93F79245FB43, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_93F79245FB43","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"19,443,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_93F79245FB43","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2015-06-23"}},{"date":"2014-04-25","until":"2015-04-24","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 3,813,000,000 United States dollar\", as of 2014-04-25 (until 2015-04-24). Claim clm_DB0956D536CC, https://asof.is/claim/clm_DB0956D536CC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_DB0956D536CC","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"3,813,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DB0956D536CC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2015, filed 2015-06-23"}},{"date":"2014-04-25","until":"2015-01-23","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 37,943,000,000 United States dollar\", as of 2014-04-25 (until 2015-01-23). Claim clm_FBFE34E530A1, https://asof.is/claim/clm_FBFE34E530A1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_FBFE34E530A1","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"37,943,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FBFE34E530A1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2015-06-23"}},{"date":"2014-06-12","until":"2014-07-25","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 0 United States dollar\", as of 2014-06-12 (until 2014-07-25). Claim clm_BC6B86225079, https://asof.is/claim/clm_BC6B86225079, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000008/0001613103-15-000008-index.htm.","url":"https://asof.is/claim/clm_BC6B86225079","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"0 United States dollar","status":"superseded","assertable":true,"id":"clm_BC6B86225079","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2015, filed 2015-02-27"}},{"date":"2014-07-14","until":"2014-11-21","published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc registrant name: Medtronic Holdings Ltd\", as of 2014-07-14 (until 2014-11-21). Claim clm_5A9BD7449980, https://asof.is/claim/clm_5A9BD7449980, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001613103.","url":"https://asof.is/claim/clm_5A9BD7449980","accessed":"2026-11-09"},"kind":"other","predicate":"registrant_name","value":"Medtronic Holdings Ltd","status":"superseded","assertable":true,"id":"clm_5A9BD7449980","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":"2014-07-25","until":"2014-10-24","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,088,000,000 United States dollar\", as of 2014-07-25 (until 2014-10-24). Claim clm_1E2BD657D88E, https://asof.is/claim/clm_1E2BD657D88E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_1E2BD657D88E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,088,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1E2BD657D88E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2014-07-25","until":"2014-10-24","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 871,000,000 United States dollar\", as of 2014-07-25 (until 2014-10-24). Claim clm_662A39CC98CB, https://asof.is/claim/clm_662A39CC98CB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_662A39CC98CB","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"871,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_662A39CC98CB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2014-07-25","until":"2014-10-24","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,336,000,000 United States dollar\", as of 2014-07-25 (until 2014-10-24). Claim clm_97D39540E69A, https://asof.is/claim/clm_97D39540E69A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_97D39540E69A","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,336,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_97D39540E69A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2014-07-25","until":"2014-10-24","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 4,273,000,000 United States dollar\", as of 2014-07-25 (until 2014-10-24). Claim clm_D8F351640B15, https://asof.is/claim/clm_D8F351640B15, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_D8F351640B15","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,273,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D8F351640B15","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2014-10-24","until":"2015-01-23","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 4,366,000,000 United States dollar\", as of 2014-10-24 (until 2015-01-23). Claim clm_51C7BDAE1018, https://asof.is/claim/clm_51C7BDAE1018, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_51C7BDAE1018","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,366,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_51C7BDAE1018","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2014-10-24","until":"2015-01-23","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 828,000,000 United States dollar\", as of 2014-10-24 (until 2015-01-23). Claim clm_62B4ECCDDA6B, https://asof.is/claim/clm_62B4ECCDDA6B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_62B4ECCDDA6B","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"828,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_62B4ECCDDA6B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2014-10-24","until":"2015-01-23","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,030,000,000 United States dollar\", as of 2014-10-24 (until 2015-01-23). Claim clm_84C766BA46CE, https://asof.is/claim/clm_84C766BA46CE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_84C766BA46CE","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,030,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_84C766BA46CE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2014-10-24","until":"2015-01-23","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,287,000,000 United States dollar\", as of 2014-10-24 (until 2015-01-23). Claim clm_FC703B74AD76, https://asof.is/claim/clm_FC703B74AD76, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_FC703B74AD76","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,287,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FC703B74AD76","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2015-01-15","until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc registrant name: Medtronic plc\", as of 2015-01-15. Claim clm_06CB035EDE66, https://asof.is/claim/clm_06CB035EDE66, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001613103.","url":"https://asof.is/claim/clm_06CB035EDE66","accessed":"2026-11-09"},"kind":"other","predicate":"registrant_name","value":"Medtronic plc","status":"valid","assertable":true,"id":"clm_06CB035EDE66","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":"2015-01-15","until":"2015-01-15","published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc registrant name: Medtronic Ltd\", as of 2015-01-15 (until 2015-01-15). Claim clm_365434F0A0EE, https://asof.is/claim/clm_365434F0A0EE, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001613103.","url":"https://asof.is/claim/clm_365434F0A0EE","accessed":"2026-11-09"},"kind":"other","predicate":"registrant_name","value":"Medtronic Ltd","status":"superseded","assertable":false,"why_not":"not_held","id":"clm_365434F0A0EE","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":"2015-01-23","until":"2015-04-24","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: -36,954,000 United States dollar\", as of 2015-01-23 (until 2015-04-24). Claim clm_1E852E336D8A, https://asof.is/claim/clm_1E852E336D8A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000008/0001613103-15-000008-index.htm.","url":"https://asof.is/claim/clm_1E852E336D8A","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"-36,954,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1E852E336D8A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2015, filed 2015-02-27"}},{"date":"2015-01-23","until":"2015-07-31","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: -37,075,000 United States dollar\", as of 2015-01-23 (until 2015-07-31). Claim clm_40EFF62649AD, https://asof.is/claim/clm_40EFF62649AD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000008/0001613103-15-000008-index.htm.","url":"https://asof.is/claim/clm_40EFF62649AD","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"-37,075,000 United States dollar","status":"superseded","assertable":true,"id":"clm_40EFF62649AD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2015, filed 2015-02-27"}},{"date":"2015-01-23","until":"2015-04-24","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 46,000 United States dollar\", as of 2015-01-23 (until 2015-04-24). Claim clm_6EE675E6EFFE, https://asof.is/claim/clm_6EE675E6EFFE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000008/0001613103-15-000008-index.htm.","url":"https://asof.is/claim/clm_6EE675E6EFFE","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"46,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6EE675E6EFFE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2015, filed 2015-02-27"}},{"date":"2015-01-23","until":"2015-04-24","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 46,000 United States dollar\", as of 2015-01-23 (until 2015-04-24). Claim clm_A2880AC8AEA0, https://asof.is/claim/clm_A2880AC8AEA0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000008/0001613103-15-000008-index.htm.","url":"https://asof.is/claim/clm_A2880AC8AEA0","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"46,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A2880AC8AEA0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2015, filed 2015-02-27"}},{"date":"2015-01-23","until":"2015-07-31","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 0 United States dollar\", as of 2015-01-23 (until 2015-07-31). Claim clm_B93C5DDBD354, https://asof.is/claim/clm_B93C5DDBD354, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000008/0001613103-15-000008-index.htm.","url":"https://asof.is/claim/clm_B93C5DDBD354","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"0 United States dollar","status":"superseded","assertable":true,"id":"clm_B93C5DDBD354","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2015, filed 2015-02-27"}},{"date":"2015-01-23","until":"2015-07-31","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,275,000,000 United States dollar\", as of 2015-01-23 (until 2015-07-31). Claim clm_CF85B2F40372, https://asof.is/claim/clm_CF85B2F40372, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_CF85B2F40372","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,275,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CF85B2F40372","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2015-02-24","until":"2015-06-16","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,425,066,824 shares\", as of 2015-02-24 (until 2015-06-16). Claim clm_657CDE6BFDB2, https://asof.is/claim/clm_657CDE6BFDB2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000008/0001613103-15-000008-index.htm.","url":"https://asof.is/claim/clm_657CDE6BFDB2","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,425,066,824 shares","status":"superseded","assertable":true,"id":"clm_657CDE6BFDB2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2015, filed 2015-02-27"}},{"date":"2015-04-24","until":"2015-07-31","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,843,000,000 United States dollar\", as of 2015-04-24 (until 2015-07-31). Claim clm_10616CE86A18, https://asof.is/claim/clm_10616CE86A18, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_10616CE86A18","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,843,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_10616CE86A18","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2015-06-23"}},{"date":"2015-04-24","until":"2016-04-29","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 20,261,000,000 United States dollar\", as of 2015-04-24 (until 2016-04-29). Claim clm_476365ACEA5E, https://asof.is/claim/clm_476365ACEA5E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_476365ACEA5E","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"20,261,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_476365ACEA5E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2015, filed 2015-06-23"}},{"date":"2015-04-24","until":"2015-07-31","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 106,685,000,000 United States dollar\", as of 2015-04-24 (until 2015-07-31). Claim clm_8517D8DF59AF, https://asof.is/claim/clm_8517D8DF59AF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_8517D8DF59AF","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"106,685,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8517D8DF59AF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2015-06-23"}},{"date":"2015-04-24","until":"2016-04-29","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 3,766,000,000 United States dollar\", as of 2015-04-24 (until 2016-04-29). Claim clm_924622784778, https://asof.is/claim/clm_924622784778, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_924622784778","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"3,766,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_924622784778","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2015, filed 2015-06-23"}},{"date":"2015-04-24","until":"2016-04-29","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 2,675,000,000 United States dollar\", as of 2015-04-24 (until 2016-04-29). Claim clm_D34DB14BA021, https://asof.is/claim/clm_D34DB14BA021, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_D34DB14BA021","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"2,675,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D34DB14BA021","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2015, filed 2015-06-23"}},{"date":"2015-04-24","until":"2015-07-31","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 53,230,000,000 United States dollar\", as of 2015-04-24 (until 2015-07-31). Claim clm_F827795B2CAB, https://asof.is/claim/clm_F827795B2CAB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_F827795B2CAB","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"53,230,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F827795B2CAB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2015-06-23"}},{"date":"2015-06-16","until":"2015-09-03","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,416,351,117 shares\", as of 2015-06-16 (until 2015-09-03). Claim clm_C066190E195C, https://asof.is/claim/clm_C066190E195C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_C066190E195C","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,416,351,117 shares","status":"superseded","assertable":true,"id":"clm_C066190E195C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2015, filed 2015-06-23"}},{"date":"2015-07-31","until":"2015-10-30","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 820,000,000 United States dollar\", as of 2015-07-31 (until 2015-10-30). Claim clm_0EC1B503CF4B, https://asof.is/claim/clm_0EC1B503CF4B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_0EC1B503CF4B","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"820,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0EC1B503CF4B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2015-07-31","until":"2015-10-30","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 104,626,000,000 United States dollar\", as of 2015-07-31 (until 2015-10-30). Claim clm_38A7D87C86D6, https://asof.is/claim/clm_38A7D87C86D6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_38A7D87C86D6","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"104,626,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_38A7D87C86D6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2015-07-31","until":"2015-10-30","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 52,809,000,000 United States dollar\", as of 2015-07-31 (until 2015-10-30). Claim clm_4EB0377461EC, https://asof.is/claim/clm_4EB0377461EC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_4EB0377461EC","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"52,809,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4EB0377461EC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2015-07-31","until":"2015-10-30","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,274,000,000 United States dollar\", as of 2015-07-31 (until 2015-10-30). Claim clm_A8CE624064A7, https://asof.is/claim/clm_A8CE624064A7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_A8CE624064A7","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,274,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A8CE624064A7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2015-07-31","until":"2015-10-30","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,131,000,000 United States dollar\", as of 2015-07-31 (until 2015-10-30). Claim clm_F337E59131E6, https://asof.is/claim/clm_F337E59131E6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_F337E59131E6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,131,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F337E59131E6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2015-07-31","until":"2015-10-30","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,979,000,000 United States dollar\", as of 2015-07-31 (until 2015-10-30). Claim clm_F39C9C3E421C, https://asof.is/claim/clm_F39C9C3E421C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_F39C9C3E421C","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,979,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F39C9C3E421C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2015-09-03","until":"2015-12-03","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,413,614,665 shares\", as of 2015-09-03 (until 2015-12-03). Claim clm_224EA5DBA60F, https://asof.is/claim/clm_224EA5DBA60F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_224EA5DBA60F","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,413,614,665 shares","status":"superseded","assertable":true,"id":"clm_224EA5DBA60F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2015-10-30","until":"2016-01-29","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,058,000,000 United States dollar\", as of 2015-10-30 (until 2016-01-29). Claim clm_56E745B66772, https://asof.is/claim/clm_56E745B66772, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_56E745B66772","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,058,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_56E745B66772","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2015-10-30","until":"2016-01-29","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,378,000,000 United States dollar\", as of 2015-10-30 (until 2016-01-29). Claim clm_587994CAB032, https://asof.is/claim/clm_587994CAB032, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_587994CAB032","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,378,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_587994CAB032","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2015-10-30","until":"2016-01-29","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,300,000,000 United States dollar\", as of 2015-10-30 (until 2016-01-29). Claim clm_84F57D5E95B9, https://asof.is/claim/clm_84F57D5E95B9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_84F57D5E95B9","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,300,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_84F57D5E95B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2015-10-30","until":"2016-01-29","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 520,000,000 United States dollar\", as of 2015-10-30 (until 2016-01-29). Claim clm_D562CC732A96, https://asof.is/claim/clm_D562CC732A96, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_D562CC732A96","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"520,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D562CC732A96","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2015-10-30","until":"2016-01-29","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 52,269,000,000 United States dollar\", as of 2015-10-30 (until 2016-01-29). Claim clm_D5E87BABAC26, https://asof.is/claim/clm_D5E87BABAC26, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_D5E87BABAC26","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"52,269,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D5E87BABAC26","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2015-10-30","until":"2016-01-29","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 104,945,000,000 United States dollar\", as of 2015-10-30 (until 2016-01-29). Claim clm_F13FA315E331, https://asof.is/claim/clm_F13FA315E331, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_F13FA315E331","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"104,945,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F13FA315E331","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2015-12-03","until":"2016-03-03","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,406,155,722 shares\", as of 2015-12-03 (until 2016-03-03). Claim clm_485A7B08D21D, https://asof.is/claim/clm_485A7B08D21D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_485A7B08D21D","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,406,155,722 shares","status":"superseded","assertable":true,"id":"clm_485A7B08D21D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2016-01-29","until":"2016-07-29","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,355,000,000 United States dollar\", as of 2016-01-29 (until 2016-07-29). Claim clm_585563FF3C79, https://asof.is/claim/clm_585563FF3C79, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_585563FF3C79","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,355,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_585563FF3C79","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2016-01-29","until":"2016-07-29","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 6,934,000,000 United States dollar\", as of 2016-01-29 (until 2016-07-29). Claim clm_6ACE3572E7E8, https://asof.is/claim/clm_6ACE3572E7E8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_6ACE3572E7E8","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"6,934,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6ACE3572E7E8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2016-01-29","until":"2016-07-29","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,095,000,000 United States dollar\", as of 2016-01-29 (until 2016-07-29). Claim clm_6F829E272A73, https://asof.is/claim/clm_6F829E272A73, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_6F829E272A73","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,095,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6F829E272A73","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2016-01-29","until":"2016-04-29","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 102,706,000,000 United States dollar\", as of 2016-01-29 (until 2016-04-29). Claim clm_72C17700819B, https://asof.is/claim/clm_72C17700819B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_72C17700819B","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"102,706,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_72C17700819B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2016-01-29","until":"2016-04-29","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,721,000,000 United States dollar\", as of 2016-01-29 (until 2016-04-29). Claim clm_851260124C55, https://asof.is/claim/clm_851260124C55, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_851260124C55","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,721,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_851260124C55","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2016-01-29","until":"2016-04-29","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,816,000,000 United States dollar\", as of 2016-01-29 (until 2016-04-29). Claim clm_E19D89E883BA, https://asof.is/claim/clm_E19D89E883BA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_E19D89E883BA","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,816,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E19D89E883BA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2016-03-03","until":"2016-06-20","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,401,043,252 shares\", as of 2016-03-03 (until 2016-06-20). Claim clm_FEDD405CBE94, https://asof.is/claim/clm_FEDD405CBE94, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_FEDD405CBE94","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,401,043,252 shares","status":"superseded","assertable":true,"id":"clm_FEDD405CBE94","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2016-04-29","until":"2017-04-28","published":"2016-06-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 5,291,000,000 United States dollar\", as of 2016-04-29 (until 2017-04-28). Claim clm_22932BDBA3C2, https://asof.is/claim/clm_22932BDBA3C2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000093/0001613103-16-000093-index.htm.","url":"https://asof.is/claim/clm_22932BDBA3C2","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"5,291,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_22932BDBA3C2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2016, filed 2016-06-28"}},{"date":"2016-04-29","until":"2016-07-29","published":"2016-06-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,876,000,000 United States dollar\", as of 2016-04-29 (until 2016-07-29). Claim clm_2D3D1B04E22A, https://asof.is/claim/clm_2D3D1B04E22A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000093/0001613103-16-000093-index.htm.","url":"https://asof.is/claim/clm_2D3D1B04E22A","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,876,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2D3D1B04E22A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2016, filed 2016-06-28"}},{"date":"2016-04-29","until":"2016-07-29","published":"2016-06-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 52,063,000,000 United States dollar\", as of 2016-04-29 (until 2016-07-29). Claim clm_8AD4069224DA, https://asof.is/claim/clm_8AD4069224DA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000093/0001613103-16-000093-index.htm.","url":"https://asof.is/claim/clm_8AD4069224DA","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"52,063,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8AD4069224DA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2016, filed 2016-06-28"}},{"date":"2016-04-29","until":"2017-04-28","published":"2016-06-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 3,538,000,000 United States dollar\", as of 2016-04-29 (until 2017-04-28). Claim clm_B5EBB0DEFB11, https://asof.is/claim/clm_B5EBB0DEFB11, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000093/0001613103-16-000093-index.htm.","url":"https://asof.is/claim/clm_B5EBB0DEFB11","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"3,538,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B5EBB0DEFB11","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2016, filed 2016-06-28"}},{"date":"2016-04-29","until":"2017-04-28","published":"2016-06-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 28,833,000,000 United States dollar\", as of 2016-04-29 (until 2017-04-28). Claim clm_E24B8D5A2678, https://asof.is/claim/clm_E24B8D5A2678, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000093/0001613103-16-000093-index.htm.","url":"https://asof.is/claim/clm_E24B8D5A2678","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"28,833,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E24B8D5A2678","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2016, filed 2016-06-28"}},{"date":"2016-04-29","until":"2016-07-29","published":"2016-06-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 99,782,000,000 United States dollar\", as of 2016-04-29 (until 2016-07-29). Claim clm_EFB89A55947E, https://asof.is/claim/clm_EFB89A55947E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000093/0001613103-16-000093-index.htm.","url":"https://asof.is/claim/clm_EFB89A55947E","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"99,782,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EFB89A55947E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2016, filed 2016-06-28"}},{"date":"2016-06-20","until":"2016-08-26","published":"2016-06-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,394,731,892 shares\", as of 2016-06-20 (until 2016-08-26). Claim clm_03FF005E69CB, https://asof.is/claim/clm_03FF005E69CB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000093/0001613103-16-000093-index.htm.","url":"https://asof.is/claim/clm_03FF005E69CB","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,394,731,892 shares","status":"superseded","assertable":true,"id":"clm_03FF005E69CB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2016, filed 2016-06-28"}},{"date":"2016-07-29","until":"2016-10-28","published":"2016-09-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,060,000,000 United States dollar\", as of 2016-07-29 (until 2016-10-28). Claim clm_40BB0270177D, https://asof.is/claim/clm_40BB0270177D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000100/0001613103-16-000100-index.htm.","url":"https://asof.is/claim/clm_40BB0270177D","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,060,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_40BB0270177D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2017, filed 2016-09-07"}},{"date":"2016-07-29","until":"2016-10-28","published":"2016-09-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 98,601,000,000 United States dollar\", as of 2016-07-29 (until 2016-10-28). Claim clm_4E245F27FBBB, https://asof.is/claim/clm_4E245F27FBBB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000100/0001613103-16-000100-index.htm.","url":"https://asof.is/claim/clm_4E245F27FBBB","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"98,601,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4E245F27FBBB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2017, filed 2016-09-07"}},{"date":"2016-07-29","until":"2016-10-28","published":"2016-09-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,166,000,000 United States dollar\", as of 2016-07-29 (until 2016-10-28). Claim clm_6F95ECF4F19B, https://asof.is/claim/clm_6F95ECF4F19B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000100/0001613103-16-000100-index.htm.","url":"https://asof.is/claim/clm_6F95ECF4F19B","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,166,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6F95ECF4F19B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2017, filed 2016-09-07"}},{"date":"2016-07-29","until":"2016-10-28","published":"2016-09-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,167,000,000 United States dollar\", as of 2016-07-29 (until 2016-10-28). Claim clm_BF030D446993, https://asof.is/claim/clm_BF030D446993, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000100/0001613103-16-000100-index.htm.","url":"https://asof.is/claim/clm_BF030D446993","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,167,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BF030D446993","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2017, filed 2016-09-07"}},{"date":"2016-07-29","until":"2016-10-28","published":"2016-09-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 929,000,000 United States dollar\", as of 2016-07-29 (until 2016-10-28). Claim clm_C7D170B4D530, https://asof.is/claim/clm_C7D170B4D530, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000100/0001613103-16-000100-index.htm.","url":"https://asof.is/claim/clm_C7D170B4D530","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"929,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C7D170B4D530","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2017, filed 2016-09-07"}},{"date":"2016-07-29","until":"2016-10-28","published":"2016-09-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,824,000,000 United States dollar\", as of 2016-07-29 (until 2016-10-28). Claim clm_EC0FA324681E, https://asof.is/claim/clm_EC0FA324681E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000100/0001613103-16-000100-index.htm.","url":"https://asof.is/claim/clm_EC0FA324681E","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,824,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EC0FA324681E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2017, filed 2016-09-07"}},{"date":"2016-08-26","until":"2016-12-01","published":"2016-09-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,381,935,603 shares\", as of 2016-08-26 (until 2016-12-01). Claim clm_8C670CEF6AB3, https://asof.is/claim/clm_8C670CEF6AB3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000100/0001613103-16-000100-index.htm.","url":"https://asof.is/claim/clm_8C670CEF6AB3","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,381,935,603 shares","status":"superseded","assertable":true,"id":"clm_8C670CEF6AB3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2017, filed 2016-09-07"}},{"date":"2016-10-28","until":"2017-01-27","published":"2016-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,385,000,000 United States dollar\", as of 2016-10-28 (until 2017-01-27). Claim clm_062671209390, https://asof.is/claim/clm_062671209390, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/0001613103-16-000123-index.htm.","url":"https://asof.is/claim/clm_062671209390","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,385,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_062671209390","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2017, filed 2016-12-05"}},{"date":"2016-10-28","until":"2017-01-27","published":"2016-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,115,000,000 United States dollar\", as of 2016-10-28 (until 2017-01-27). Claim clm_25E745C03D63, https://asof.is/claim/clm_25E745C03D63, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/0001613103-16-000123-index.htm.","url":"https://asof.is/claim/clm_25E745C03D63","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,115,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_25E745C03D63","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2017, filed 2016-12-05"}},{"date":"2016-10-28","until":"2017-01-27","published":"2016-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,186,000,000 United States dollar\", as of 2016-10-28 (until 2017-01-27). Claim clm_5C0909162C74, https://asof.is/claim/clm_5C0909162C74, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/0001613103-16-000123-index.htm.","url":"https://asof.is/claim/clm_5C0909162C74","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,186,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5C0909162C74","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2017, filed 2016-12-05"}},{"date":"2016-10-28","until":"2017-01-27","published":"2016-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,954,000,000 United States dollar\", as of 2016-10-28 (until 2017-01-27). Claim clm_6018A9787332, https://asof.is/claim/clm_6018A9787332, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/0001613103-16-000123-index.htm.","url":"https://asof.is/claim/clm_6018A9787332","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,954,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6018A9787332","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2017, filed 2016-12-05"}},{"date":"2016-10-28","until":"2017-01-27","published":"2016-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 98,406,000,000 United States dollar\", as of 2016-10-28 (until 2017-01-27). Claim clm_7934D30E0B54, https://asof.is/claim/clm_7934D30E0B54, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/0001613103-16-000123-index.htm.","url":"https://asof.is/claim/clm_7934D30E0B54","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"98,406,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7934D30E0B54","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2017, filed 2016-12-05"}},{"date":"2016-10-28","until":"2017-01-27","published":"2016-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,345,000,000 United States dollar\", as of 2016-10-28 (until 2017-01-27). Claim clm_88D2CF2BD972, https://asof.is/claim/clm_88D2CF2BD972, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/0001613103-16-000123-index.htm.","url":"https://asof.is/claim/clm_88D2CF2BD972","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,345,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_88D2CF2BD972","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2017, filed 2016-12-05"}},{"date":"2016-12-01","until":"2017-03-01","published":"2016-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,373,047,310 shares\", as of 2016-12-01 (until 2017-03-01). Claim clm_9ABAE095795D, https://asof.is/claim/clm_9ABAE095795D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/0001613103-16-000123-index.htm.","url":"https://asof.is/claim/clm_9ABAE095795D","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,373,047,310 shares","status":"superseded","assertable":true,"id":"clm_9ABAE095795D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2017, filed 2016-12-05"}},{"date":"2017-01-27","until":"2017-07-28","published":"2017-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 821,000,000 United States dollar\", as of 2017-01-27 (until 2017-07-28). Claim clm_05A984366E3D, https://asof.is/claim/clm_05A984366E3D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000008/0001613103-17-000008-index.htm.","url":"https://asof.is/claim/clm_05A984366E3D","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"821,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_05A984366E3D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2017, filed 2017-03-03"}},{"date":"2017-01-27","until":"2017-07-28","published":"2017-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,283,000,000 United States dollar\", as of 2017-01-27 (until 2017-07-28). Claim clm_41506301E658, https://asof.is/claim/clm_41506301E658, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000008/0001613103-17-000008-index.htm.","url":"https://asof.is/claim/clm_41506301E658","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,283,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_41506301E658","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2017, filed 2017-03-03"}},{"date":"2017-01-27","until":"2017-04-28","published":"2017-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 49,387,000,000 United States dollar\", as of 2017-01-27 (until 2017-04-28). Claim clm_475F64C21E44, https://asof.is/claim/clm_475F64C21E44, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000008/0001613103-17-000008-index.htm.","url":"https://asof.is/claim/clm_475F64C21E44","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"49,387,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_475F64C21E44","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2017, filed 2017-03-03"}},{"date":"2017-01-27","until":"2017-07-28","published":"2017-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,147,000,000 United States dollar\", as of 2017-01-27 (until 2017-07-28). Claim clm_588061E8A790, https://asof.is/claim/clm_588061E8A790, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000008/0001613103-17-000008-index.htm.","url":"https://asof.is/claim/clm_588061E8A790","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,147,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_588061E8A790","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2017, filed 2017-03-03"}},{"date":"2017-01-27","until":"2017-04-28","published":"2017-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 97,578,000,000 United States dollar\", as of 2017-01-27 (until 2017-04-28). Claim clm_7913D691A0CD, https://asof.is/claim/clm_7913D691A0CD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000008/0001613103-17-000008-index.htm.","url":"https://asof.is/claim/clm_7913D691A0CD","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"97,578,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7913D691A0CD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2017, filed 2017-03-03"}},{"date":"2017-01-27","until":"2017-04-28","published":"2017-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,768,000,000 United States dollar\", as of 2017-01-27 (until 2017-04-28). Claim clm_EAA9127C4FA1, https://asof.is/claim/clm_EAA9127C4FA1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000008/0001613103-17-000008-index.htm.","url":"https://asof.is/claim/clm_EAA9127C4FA1","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,768,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EAA9127C4FA1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2017, filed 2017-03-03"}},{"date":"2017-03-01","until":"2017-06-21","published":"2017-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,368,884,991 shares\", as of 2017-03-01 (until 2017-06-21). Claim clm_48EA845391DB, https://asof.is/claim/clm_48EA845391DB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000008/0001613103-17-000008-index.htm.","url":"https://asof.is/claim/clm_48EA845391DB","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,368,884,991 shares","status":"superseded","assertable":true,"id":"clm_48EA845391DB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2017, filed 2017-03-03"}},{"date":"2017-04-28","until":"2018-04-27","published":"2017-06-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 5,330,000,000 United States dollar\", as of 2017-04-28 (until 2018-04-27). Claim clm_1B1A420A0CE0, https://asof.is/claim/clm_1B1A420A0CE0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000018/0001613103-17-000018-index.htm.","url":"https://asof.is/claim/clm_1B1A420A0CE0","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"5,330,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1B1A420A0CE0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2017, filed 2017-06-27"}},{"date":"2017-04-28","until":"2017-07-28","published":"2017-06-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,967,000,000 United States dollar\", as of 2017-04-28 (until 2017-07-28). Claim clm_1F712BE9A602, https://asof.is/claim/clm_1F712BE9A602, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000018/0001613103-17-000018-index.htm.","url":"https://asof.is/claim/clm_1F712BE9A602","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,967,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1F712BE9A602","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2017, filed 2017-06-27"}},{"date":"2017-04-28","until":"2018-04-27","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 29,710,000,000 United States dollar\", as of 2017-04-28 (until 2018-04-27). Claim clm_41C2C6ED3D43, https://asof.is/claim/clm_41C2C6ED3D43, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_41C2C6ED3D43","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"29,710,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_41C2C6ED3D43","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2019, filed 2019-06-21"}},{"date":"2017-04-28","until":"2017-07-28","published":"2017-06-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 99,816,000,000 United States dollar\", as of 2017-04-28 (until 2017-07-28). Claim clm_C2401DCD13E2, https://asof.is/claim/clm_C2401DCD13E2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000018/0001613103-17-000018-index.htm.","url":"https://asof.is/claim/clm_C2401DCD13E2","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"99,816,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C2401DCD13E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2017, filed 2017-06-27"}},{"date":"2017-04-28","until":"2017-07-28","published":"2017-06-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,294,000,000 United States dollar\", as of 2017-04-28 (until 2017-07-28). Claim clm_EEF81E06C0FE, https://asof.is/claim/clm_EEF81E06C0FE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000018/0001613103-17-000018-index.htm.","url":"https://asof.is/claim/clm_EEF81E06C0FE","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,294,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EEF81E06C0FE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2017, filed 2017-06-27"}},{"date":"2017-04-28","until":"2018-04-27","published":"2017-06-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 4,028,000,000 United States dollar\", as of 2017-04-28 (until 2018-04-27). Claim clm_FB2E99BC240A, https://asof.is/claim/clm_FB2E99BC240A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000018/0001613103-17-000018-index.htm.","url":"https://asof.is/claim/clm_FB2E99BC240A","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"4,028,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FB2E99BC240A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2017, filed 2017-06-27"}},{"date":"2017-06-21","until":"2017-08-29","published":"2017-06-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,359,026,669 shares\", as of 2017-06-21 (until 2017-08-29). Claim clm_E45654A9CC60, https://asof.is/claim/clm_E45654A9CC60, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000018/0001613103-17-000018-index.htm.","url":"https://asof.is/claim/clm_E45654A9CC60","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,359,026,669 shares","status":"superseded","assertable":true,"id":"clm_E45654A9CC60","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2017, filed 2017-06-27"}},{"date":"2017-07-28","until":"2017-10-27","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,390,000,000 United States dollar\", as of 2017-07-28 (until 2017-10-27). Claim clm_0D4811D29537, https://asof.is/claim/clm_0D4811D29537, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_0D4811D29537","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,390,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0D4811D29537","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2017-07-28","until":"2017-10-27","published":"2017-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,672,000,000 United States dollar\", as of 2017-07-28 (until 2017-10-27). Claim clm_230376012C50, https://asof.is/claim/clm_230376012C50, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000027/0001613103-17-000027-index.htm.","url":"https://asof.is/claim/clm_230376012C50","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,672,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_230376012C50","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2018, filed 2017-09-01"}},{"date":"2017-07-28","until":"2017-10-27","published":"2017-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,389,000,000 United States dollar\", as of 2017-07-28 (until 2017-10-27). Claim clm_2A0B30C877E2, https://asof.is/claim/clm_2A0B30C877E2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000027/0001613103-17-000027-index.htm.","url":"https://asof.is/claim/clm_2A0B30C877E2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,389,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2A0B30C877E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2018, filed 2017-09-01"}},{"date":"2017-07-28","until":"2017-10-27","published":"2017-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,016,000,000 United States dollar\", as of 2017-07-28 (until 2017-10-27). Claim clm_97055FD1CD3E, https://asof.is/claim/clm_97055FD1CD3E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000027/0001613103-17-000027-index.htm.","url":"https://asof.is/claim/clm_97055FD1CD3E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,016,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_97055FD1CD3E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2018, filed 2017-09-01"}},{"date":"2017-07-28","until":"2017-10-27","published":"2017-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,691,000,000 United States dollar\", as of 2017-07-28 (until 2017-10-27). Claim clm_DF2958F57D4F, https://asof.is/claim/clm_DF2958F57D4F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000027/0001613103-17-000027-index.htm.","url":"https://asof.is/claim/clm_DF2958F57D4F","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,691,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DF2958F57D4F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2018, filed 2017-09-01"}},{"date":"2017-07-28","until":"2017-10-27","published":"2017-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 100,250,000,000 United States dollar\", as of 2017-07-28 (until 2017-10-27). Claim clm_F448A4E941FA, https://asof.is/claim/clm_F448A4E941FA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000027/0001613103-17-000027-index.htm.","url":"https://asof.is/claim/clm_F448A4E941FA","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"100,250,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F448A4E941FA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2018, filed 2017-09-01"}},{"date":"2017-08-29","until":"2017-11-28","published":"2017-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,354,591,435 shares\", as of 2017-08-29 (until 2017-11-28). Claim clm_F9C29B1B84D6, https://asof.is/claim/clm_F9C29B1B84D6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000027/0001613103-17-000027-index.htm.","url":"https://asof.is/claim/clm_F9C29B1B84D6","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,354,591,435 shares","status":"superseded","assertable":true,"id":"clm_F9C29B1B84D6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2018, filed 2017-09-01"}},{"date":"2017-10-27","until":"2018-01-26","published":"2017-12-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 5,529,000,000 United States dollar\", as of 2017-10-27 (until 2018-01-26). Claim clm_0A3BE79233EF, https://asof.is/claim/clm_0A3BE79233EF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000047/0001613103-17-000047-index.htm.","url":"https://asof.is/claim/clm_0A3BE79233EF","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,529,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0A3BE79233EF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2018, filed 2017-12-04"}},{"date":"2017-10-27","until":"2018-01-26","published":"2017-12-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 2,017,000,000 United States dollar\", as of 2017-10-27 (until 2018-01-26). Claim clm_98981357542B, https://asof.is/claim/clm_98981357542B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000047/0001613103-17-000047-index.htm.","url":"https://asof.is/claim/clm_98981357542B","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,017,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_98981357542B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2018, filed 2017-12-04"}},{"date":"2017-10-27","until":"2018-01-26","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,050,000,000 United States dollar\", as of 2017-10-27 (until 2018-01-26). Claim clm_A7109B19CCB4, https://asof.is/claim/clm_A7109B19CCB4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_A7109B19CCB4","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,050,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A7109B19CCB4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2017-10-27","until":"2018-01-26","published":"2017-12-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,901,000,000 United States dollar\", as of 2017-10-27 (until 2018-01-26). Claim clm_BF5725B97F76, https://asof.is/claim/clm_BF5725B97F76, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000047/0001613103-17-000047-index.htm.","url":"https://asof.is/claim/clm_BF5725B97F76","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,901,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BF5725B97F76","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2018, filed 2017-12-04"}},{"date":"2017-10-27","until":"2018-01-26","published":"2017-12-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 94,458,000,000 United States dollar\", as of 2017-10-27 (until 2018-01-26). Claim clm_C17F98BD8BDE, https://asof.is/claim/clm_C17F98BD8BDE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000047/0001613103-17-000047-index.htm.","url":"https://asof.is/claim/clm_C17F98BD8BDE","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"94,458,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C17F98BD8BDE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2018, filed 2017-12-04"}},{"date":"2017-10-27","until":"2018-01-26","published":"2017-12-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,469,000,000 United States dollar\", as of 2017-10-27 (until 2018-01-26). Claim clm_C4336406E307, https://asof.is/claim/clm_C4336406E307, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000047/0001613103-17-000047-index.htm.","url":"https://asof.is/claim/clm_C4336406E307","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"51,469,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C4336406E307","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2018, filed 2017-12-04"}},{"date":"2017-11-28","until":"2018-02-28","published":"2017-12-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,353,498,000 shares\", as of 2017-11-28 (until 2018-02-28). Claim clm_416968D585EC, https://asof.is/claim/clm_416968D585EC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000047/0001613103-17-000047-index.htm.","url":"https://asof.is/claim/clm_416968D585EC","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,353,498,000 shares","status":"superseded","assertable":true,"id":"clm_416968D585EC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2018, filed 2017-12-04"}},{"date":"2018-01-26","until":"2018-04-27","published":"2018-03-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,234,000,000 United States dollar\", as of 2018-01-26 (until 2018-04-27). Claim clm_3F80516C6CBC, https://asof.is/claim/clm_3F80516C6CBC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000009/0001613103-18-000009-index.htm.","url":"https://asof.is/claim/clm_3F80516C6CBC","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,234,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3F80516C6CBC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2018, filed 2018-03-02"}},{"date":"2018-01-26","until":"2018-04-27","published":"2018-03-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 6,358,000,000 United States dollar\", as of 2018-01-26 (until 2018-04-27). Claim clm_56867F03A3B0, https://asof.is/claim/clm_56867F03A3B0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000009/0001613103-18-000009-index.htm.","url":"https://asof.is/claim/clm_56867F03A3B0","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"6,358,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_56867F03A3B0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2018, filed 2018-03-02"}},{"date":"2018-01-26","until":"2018-07-27","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,369,000,000 United States dollar\", as of 2018-01-26 (until 2018-07-27). Claim clm_90E5ED91F9D3, https://asof.is/claim/clm_90E5ED91F9D3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_90E5ED91F9D3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,369,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_90E5ED91F9D3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2018-01-26","until":"2018-07-27","published":"2018-03-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: -1,389,000,000 United States dollar\", as of 2018-01-26 (until 2018-07-27). Claim clm_937F4D57A278, https://asof.is/claim/clm_937F4D57A278, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000009/0001613103-18-000009-index.htm.","url":"https://asof.is/claim/clm_937F4D57A278","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"-1,389,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_937F4D57A278","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2018, filed 2018-03-02"}},{"date":"2018-01-26","until":"2018-04-27","published":"2018-03-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 95,800,000,000 United States dollar\", as of 2018-01-26 (until 2018-04-27). Claim clm_9FEEBE229A5F, https://asof.is/claim/clm_9FEEBE229A5F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000009/0001613103-18-000009-index.htm.","url":"https://asof.is/claim/clm_9FEEBE229A5F","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"95,800,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9FEEBE229A5F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2018, filed 2018-03-02"}},{"date":"2018-01-26","until":"2018-07-27","published":"2018-03-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,426,000,000 United States dollar\", as of 2018-01-26 (until 2018-07-27). Claim clm_E3877660F522, https://asof.is/claim/clm_E3877660F522, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000009/0001613103-18-000009-index.htm.","url":"https://asof.is/claim/clm_E3877660F522","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,426,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E3877660F522","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2018, filed 2018-03-02"}},{"date":"2018-02-28","until":"2018-06-20","published":"2018-03-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,355,373,428 shares\", as of 2018-02-28 (until 2018-06-20). Claim clm_C36C3B674A81, https://asof.is/claim/clm_C36C3B674A81, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000009/0001613103-18-000009-index.htm.","url":"https://asof.is/claim/clm_C36C3B674A81","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,355,373,428 shares","status":"superseded","assertable":true,"id":"clm_C36C3B674A81","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2018, filed 2018-03-02"}},{"date":"2018-04-27","until":"2019-04-26","published":"2018-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 3,104,000,000 United States dollar\", as of 2018-04-27 (until 2019-04-26). Claim clm_1D350C62378D, https://asof.is/claim/clm_1D350C62378D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000024/0001613103-18-000024-index.htm.","url":"https://asof.is/claim/clm_1D350C62378D","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"3,104,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1D350C62378D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2018, filed 2018-06-22"}},{"date":"2018-04-27","until":"2018-07-27","published":"2018-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,720,000,000 United States dollar\", as of 2018-04-27 (until 2018-07-27). Claim clm_5F7EC435D37B, https://asof.is/claim/clm_5F7EC435D37B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000024/0001613103-18-000024-index.htm.","url":"https://asof.is/claim/clm_5F7EC435D37B","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,720,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5F7EC435D37B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2018, filed 2018-06-22"}},{"date":"2018-04-27","until":"2019-04-26","published":"2018-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 6,651,000,000 United States dollar\", as of 2018-04-27 (until 2019-04-26). Claim clm_6049C30FBFCA, https://asof.is/claim/clm_6049C30FBFCA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000024/0001613103-18-000024-index.htm.","url":"https://asof.is/claim/clm_6049C30FBFCA","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"6,651,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6049C30FBFCA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2018, filed 2018-06-22"}},{"date":"2018-04-27","until":"2018-07-27","published":"2018-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,669,000,000 United States dollar\", as of 2018-04-27 (until 2018-07-27). Claim clm_65AC21F43262, https://asof.is/claim/clm_65AC21F43262, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000024/0001613103-18-000024-index.htm.","url":"https://asof.is/claim/clm_65AC21F43262","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,669,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_65AC21F43262","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2018, filed 2018-06-22"}},{"date":"2018-04-27","until":"2018-07-27","published":"2018-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,393,000,000 United States dollar\", as of 2018-04-27 (until 2018-07-27). Claim clm_7C629CA745CD, https://asof.is/claim/clm_7C629CA745CD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000024/0001613103-18-000024-index.htm.","url":"https://asof.is/claim/clm_7C629CA745CD","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"91,393,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7C629CA745CD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2018, filed 2018-06-22"}},{"date":"2018-04-27","until":"2019-04-26","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 29,953,000,000 United States dollar\", as of 2018-04-27 (until 2019-04-26). Claim clm_9D3EF5C9B280, https://asof.is/claim/clm_9D3EF5C9B280, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_9D3EF5C9B280","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"29,953,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9D3EF5C9B280","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2019, filed 2019-06-21"}},{"date":"2018-06-20","until":"2018-08-29","published":"2018-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,351,709,097 shares\", as of 2018-06-20 (until 2018-08-29). Claim clm_23192C82342B, https://asof.is/claim/clm_23192C82342B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000024/0001613103-18-000024-index.htm.","url":"https://asof.is/claim/clm_23192C82342B","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,351,709,097 shares","status":"superseded","assertable":true,"id":"clm_23192C82342B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2018, filed 2018-06-22"}},{"date":"2018-07-27","until":"2018-10-26","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,236,000,000 United States dollar\", as of 2018-07-27 (until 2018-10-26). Claim clm_0BDBD672E63A, https://asof.is/claim/clm_0BDBD672E63A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_0BDBD672E63A","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,236,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0BDBD672E63A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2018-07-27","until":"2018-10-26","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,224,000,000 United States dollar\", as of 2018-07-27 (until 2018-10-26). Claim clm_163478678504, https://asof.is/claim/clm_163478678504, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_163478678504","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,224,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_163478678504","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2018-07-27","until":"2018-10-26","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,075,000,000 United States dollar\", as of 2018-07-27 (until 2018-10-26). Claim clm_404BE8D71326, https://asof.is/claim/clm_404BE8D71326, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_404BE8D71326","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,075,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_404BE8D71326","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2018-07-27","until":"2018-10-26","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,380,000,000 United States dollar\", as of 2018-07-27 (until 2018-10-26). Claim clm_5628A8B9FD9C, https://asof.is/claim/clm_5628A8B9FD9C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_5628A8B9FD9C","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,380,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5628A8B9FD9C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2018-07-27","until":"2018-10-26","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,384,000,000 United States dollar\", as of 2018-07-27 (until 2018-10-26). Claim clm_B1E5110AD718, https://asof.is/claim/clm_B1E5110AD718, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_B1E5110AD718","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,384,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B1E5110AD718","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2018-07-27","until":"2018-10-26","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 89,721,000,000 United States dollar\", as of 2018-07-27 (until 2018-10-26). Claim clm_D5A6FCB1C8B0, https://asof.is/claim/clm_D5A6FCB1C8B0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_D5A6FCB1C8B0","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"89,721,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D5A6FCB1C8B0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2018-08-29","until":"2018-11-27","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,350,511,193 shares\", as of 2018-08-29 (until 2018-11-27). Claim clm_7CC3292BE3B1, https://asof.is/claim/clm_7CC3292BE3B1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_7CC3292BE3B1","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,350,511,193 shares","status":"superseded","assertable":true,"id":"clm_7CC3292BE3B1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2018-10-26","until":"2019-01-25","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,911,000,000 United States dollar\", as of 2018-10-26 (until 2019-01-25). Claim clm_46919521610B, https://asof.is/claim/clm_46919521610B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_46919521610B","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,911,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_46919521610B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2018-10-26","until":"2019-01-25","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,115,000,000 United States dollar\", as of 2018-10-26 (until 2019-01-25). Claim clm_9F0B8103AEBE, https://asof.is/claim/clm_9F0B8103AEBE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_9F0B8103AEBE","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,115,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9F0B8103AEBE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2018-10-26","until":"2019-01-25","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 49,607,000,000 United States dollar\", as of 2018-10-26 (until 2019-01-25). Claim clm_A20BFFCCAB66, https://asof.is/claim/clm_A20BFFCCAB66, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_A20BFFCCAB66","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"49,607,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A20BFFCCAB66","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2018-10-26","until":"2019-01-25","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,481,000,000 United States dollar\", as of 2018-10-26 (until 2019-01-25). Claim clm_D419727C14A4, https://asof.is/claim/clm_D419727C14A4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_D419727C14A4","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,481,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D419727C14A4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2018-10-26","until":"2019-01-25","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,544,000,000 United States dollar\", as of 2018-10-26 (until 2019-01-25). Claim clm_E6C4FF4AB440, https://asof.is/claim/clm_E6C4FF4AB440, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_E6C4FF4AB440","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,544,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E6C4FF4AB440","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2018-10-26","until":"2019-01-25","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 88,150,000,000 United States dollar\", as of 2018-10-26 (until 2019-01-25). Claim clm_FBF333586648, https://asof.is/claim/clm_FBF333586648, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_FBF333586648","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"88,150,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FBF333586648","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2018-11-27","until":"2019-02-27","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,343,045,417 shares\", as of 2018-11-27 (until 2019-02-27). Claim clm_4C7A460E196A, https://asof.is/claim/clm_4C7A460E196A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_4C7A460E196A","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,343,045,417 shares","status":"superseded","assertable":true,"id":"clm_4C7A460E196A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2019-01-25","until":"2019-04-26","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 88,730,000,000 United States dollar\", as of 2019-01-25 (until 2019-04-26). Claim clm_0EA45C5F3414, https://asof.is/claim/clm_0EA45C5F3414, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_0EA45C5F3414","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"88,730,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0EA45C5F3414","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2019-01-25","until":"2019-07-26","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,542,000,000 United States dollar\", as of 2019-01-25 (until 2019-07-26). Claim clm_484BB135F1E2, https://asof.is/claim/clm_484BB135F1E2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_484BB135F1E2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,542,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_484BB135F1E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2019-01-25","until":"2019-04-26","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,703,000,000 United States dollar\", as of 2019-01-25 (until 2019-04-26). Claim clm_6054C7910FB2, https://asof.is/claim/clm_6054C7910FB2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_6054C7910FB2","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,703,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6054C7910FB2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2019-01-25","until":"2019-04-26","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 49,829,000,000 United States dollar\", as of 2019-01-25 (until 2019-04-26). Claim clm_9D19EFDBD2A3, https://asof.is/claim/clm_9D19EFDBD2A3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_9D19EFDBD2A3","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"49,829,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9D19EFDBD2A3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2019-01-25","until":"2019-07-26","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,546,000,000 United States dollar\", as of 2019-01-25 (until 2019-07-26). Claim clm_B2999BC5FF39, https://asof.is/claim/clm_B2999BC5FF39, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_B2999BC5FF39","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,546,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B2999BC5FF39","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2019-01-25","until":"2019-07-26","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,269,000,000 United States dollar\", as of 2019-01-25 (until 2019-07-26). Claim clm_BD510F84A18A, https://asof.is/claim/clm_BD510F84A18A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_BD510F84A18A","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,269,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BD510F84A18A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2019-02-27","until":"2019-06-18","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,341,150,970 shares\", as of 2019-02-27 (until 2019-06-18). Claim clm_BEA377BA2F58, https://asof.is/claim/clm_BEA377BA2F58, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_BEA377BA2F58","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,341,150,970 shares","status":"superseded","assertable":true,"id":"clm_BEA377BA2F58","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2019-04-26","until":"2020-04-24","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 6,268,000,000 United States dollar\", as of 2019-04-26 (until 2020-04-24). Claim clm_0067F00D4CDE, https://asof.is/claim/clm_0067F00D4CDE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_0067F00D4CDE","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"6,268,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0067F00D4CDE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2019, filed 2019-06-21"}},{"date":"2019-04-26","until":"2020-04-24","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 30,557,000,000 United States dollar\", as of 2019-04-26 (until 2020-04-24). Claim clm_1227E23E21F9, https://asof.is/claim/clm_1227E23E21F9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_1227E23E21F9","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"30,557,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1227E23E21F9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2019, filed 2019-06-21"}},{"date":"2019-04-26","until":"2019-07-26","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 89,694,000,000 United States dollar\", as of 2019-04-26 (until 2019-07-26). Claim clm_14BADA215086, https://asof.is/claim/clm_14BADA215086, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_14BADA215086","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"89,694,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_14BADA215086","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2019-06-21"}},{"date":"2019-04-26","until":"2020-04-24","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 4,631,000,000 United States dollar\", as of 2019-04-26 (until 2020-04-24). Claim clm_1821662E3259, https://asof.is/claim/clm_1821662E3259, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_1821662E3259","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"4,631,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1821662E3259","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2019, filed 2019-06-21"}},{"date":"2019-04-26","until":"2019-07-26","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,393,000,000 United States dollar\", as of 2019-04-26 (until 2019-07-26). Claim clm_6C081FC7A5BE, https://asof.is/claim/clm_6C081FC7A5BE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_6C081FC7A5BE","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,393,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6C081FC7A5BE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2019, filed 2019-06-21"}},{"date":"2019-04-26","until":"2019-07-26","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,091,000,000 United States dollar\", as of 2019-04-26 (until 2019-07-26). Claim clm_8E1FEF7D6D04, https://asof.is/claim/clm_8E1FEF7D6D04, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_8E1FEF7D6D04","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,091,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8E1FEF7D6D04","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2019, filed 2019-06-21"}},{"date":"2019-06-18","until":"2019-08-27","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,341,156,703 shares\", as of 2019-06-18 (until 2019-08-27). Claim clm_CE61468DA19E, https://asof.is/claim/clm_CE61468DA19E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_CE61468DA19E","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,341,156,703 shares","status":"superseded","assertable":true,"id":"clm_CE61468DA19E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2019, filed 2019-06-21"}},{"date":"2019-07-26","until":"2019-10-25","published":"2019-08-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,493,000,000 United States dollar\", as of 2019-07-26 (until 2019-10-25). Claim clm_75AE288702B8, https://asof.is/claim/clm_75AE288702B8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000038/0001613103-19-000038-index.htm.","url":"https://asof.is/claim/clm_75AE288702B8","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,493,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_75AE288702B8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2020, filed 2019-08-30"}},{"date":"2019-07-26","until":"2019-10-25","published":"2019-08-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 5,080,000,000 United States dollar\", as of 2019-07-26 (until 2019-10-25). Claim clm_777BB5E82BAE, https://asof.is/claim/clm_777BB5E82BAE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000038/0001613103-19-000038-index.htm.","url":"https://asof.is/claim/clm_777BB5E82BAE","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,080,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_777BB5E82BAE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2020, filed 2019-08-30"}},{"date":"2019-07-26","until":"2019-10-25","published":"2019-08-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,485,000,000 United States dollar\", as of 2019-07-26 (until 2019-10-25). Claim clm_847D9D4FF785, https://asof.is/claim/clm_847D9D4FF785, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000038/0001613103-19-000038-index.htm.","url":"https://asof.is/claim/clm_847D9D4FF785","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,485,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_847D9D4FF785","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2020, filed 2019-08-30"}},{"date":"2019-07-26","until":"2019-10-25","published":"2019-08-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,363,000,000 United States dollar\", as of 2019-07-26 (until 2019-10-25). Claim clm_8A1DF5A7E9FD, https://asof.is/claim/clm_8A1DF5A7E9FD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000038/0001613103-19-000038-index.htm.","url":"https://asof.is/claim/clm_8A1DF5A7E9FD","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,363,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8A1DF5A7E9FD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2020, filed 2019-08-30"}},{"date":"2019-07-26","until":"2019-10-25","published":"2019-08-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,268,000,000 United States dollar\", as of 2019-07-26 (until 2019-10-25). Claim clm_DBDDF77F8B5A, https://asof.is/claim/clm_DBDDF77F8B5A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000038/0001613103-19-000038-index.htm.","url":"https://asof.is/claim/clm_DBDDF77F8B5A","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"91,268,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DBDDF77F8B5A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2020, filed 2019-08-30"}},{"date":"2019-07-26","until":"2019-10-25","published":"2019-08-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 864,000,000 United States dollar\", as of 2019-07-26 (until 2019-10-25). Claim clm_E6C78A6A8D47, https://asof.is/claim/clm_E6C78A6A8D47, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000038/0001613103-19-000038-index.htm.","url":"https://asof.is/claim/clm_E6C78A6A8D47","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"864,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E6C78A6A8D47","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2020, filed 2019-08-30"}},{"date":"2019-08-27","until":"2019-11-27","published":"2019-08-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,341,669,471 shares\", as of 2019-08-27 (until 2019-11-27). Claim clm_452BC361C963, https://asof.is/claim/clm_452BC361C963, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000038/0001613103-19-000038-index.htm.","url":"https://asof.is/claim/clm_452BC361C963","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,341,669,471 shares","status":"superseded","assertable":true,"id":"clm_452BC361C963","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2020, filed 2019-08-30"}},{"date":"2019-10-25","until":"2020-01-24","published":"2019-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,351,000,000 United States dollar\", as of 2019-10-25 (until 2020-01-24). Claim clm_76CF0E9C5D01, https://asof.is/claim/clm_76CF0E9C5D01, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/0001613103-19-000056-index.htm.","url":"https://asof.is/claim/clm_76CF0E9C5D01","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,351,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_76CF0E9C5D01","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2020, filed 2019-12-03"}},{"date":"2019-10-25","until":"2020-01-24","published":"2019-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,053,000,000 United States dollar\", as of 2019-10-25 (until 2020-01-24). Claim clm_8D6E98F70391, https://asof.is/claim/clm_8D6E98F70391, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/0001613103-19-000056-index.htm.","url":"https://asof.is/claim/clm_8D6E98F70391","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"91,053,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8D6E98F70391","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2020, filed 2019-12-03"}},{"date":"2019-10-25","until":"2020-01-24","published":"2019-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,578,000,000 United States dollar\", as of 2019-10-25 (until 2020-01-24). Claim clm_C8C06B828EFC, https://asof.is/claim/clm_C8C06B828EFC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/0001613103-19-000056-index.htm.","url":"https://asof.is/claim/clm_C8C06B828EFC","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,578,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C8C06B828EFC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2020, filed 2019-12-03"}},{"date":"2019-10-25","until":"2020-01-24","published":"2019-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,364,000,000 United States dollar\", as of 2019-10-25 (until 2020-01-24). Claim clm_CB67B1B0A972, https://asof.is/claim/clm_CB67B1B0A972, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/0001613103-19-000056-index.htm.","url":"https://asof.is/claim/clm_CB67B1B0A972","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,364,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CB67B1B0A972","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2020, filed 2019-12-03"}},{"date":"2019-10-25","until":"2020-01-24","published":"2019-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,962,000,000 United States dollar\", as of 2019-10-25 (until 2020-01-24). Claim clm_E0F778E4FBF7, https://asof.is/claim/clm_E0F778E4FBF7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/0001613103-19-000056-index.htm.","url":"https://asof.is/claim/clm_E0F778E4FBF7","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,962,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E0F778E4FBF7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2020, filed 2019-12-03"}},{"date":"2019-10-25","until":"2020-01-24","published":"2019-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,706,000,000 United States dollar\", as of 2019-10-25 (until 2020-01-24). Claim clm_E83D50C88280, https://asof.is/claim/clm_E83D50C88280, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/0001613103-19-000056-index.htm.","url":"https://asof.is/claim/clm_E83D50C88280","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,706,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E83D50C88280","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2020, filed 2019-12-03"}},{"date":"2019-11-27","until":"2020-02-25","published":"2019-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,340,377,511 shares\", as of 2019-11-27 (until 2020-02-25). Claim clm_F8E994F4C73A, https://asof.is/claim/clm_F8E994F4C73A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/0001613103-19-000056-index.htm.","url":"https://asof.is/claim/clm_F8E994F4C73A","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,340,377,511 shares","status":"superseded","assertable":true,"id":"clm_F8E994F4C73A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2020, filed 2019-12-03"}},{"date":"2020-01-24","until":"2020-04-24","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,808,000,000 United States dollar\", as of 2020-01-24 (until 2020-04-24). Claim clm_340BB97B1D16, https://asof.is/claim/clm_340BB97B1D16, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/0001613103-20-000007-index.htm.","url":"https://asof.is/claim/clm_340BB97B1D16","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"51,808,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_340BB97B1D16","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2020, filed 2020-02-28"}},{"date":"2020-01-24","until":"2020-07-31","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,639,000,000 United States dollar\", as of 2020-01-24 (until 2020-07-31). Claim clm_487D8E9DC86B, https://asof.is/claim/clm_487D8E9DC86B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/0001613103-20-000007-index.htm.","url":"https://asof.is/claim/clm_487D8E9DC86B","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,639,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_487D8E9DC86B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2020, filed 2020-02-28"}},{"date":"2020-01-24","until":"2020-04-24","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,709,000,000 United States dollar\", as of 2020-01-24 (until 2020-04-24). Claim clm_4D4F45CB9A34, https://asof.is/claim/clm_4D4F45CB9A34, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/0001613103-20-000007-index.htm.","url":"https://asof.is/claim/clm_4D4F45CB9A34","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,709,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4D4F45CB9A34","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2020, filed 2020-02-28"}},{"date":"2020-01-24","until":"2020-07-31","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,717,000,000 United States dollar\", as of 2020-01-24 (until 2020-07-31). Claim clm_85A9357A3FE4, https://asof.is/claim/clm_85A9357A3FE4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/0001613103-20-000007-index.htm.","url":"https://asof.is/claim/clm_85A9357A3FE4","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,717,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_85A9357A3FE4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2020, filed 2020-02-28"}},{"date":"2020-01-24","until":"2020-04-24","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 92,822,000,000 United States dollar\", as of 2020-01-24 (until 2020-04-24). Claim clm_DD76E60D2B7E, https://asof.is/claim/clm_DD76E60D2B7E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/0001613103-20-000007-index.htm.","url":"https://asof.is/claim/clm_DD76E60D2B7E","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"92,822,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DD76E60D2B7E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2020, filed 2020-02-28"}},{"date":"2020-01-24","until":"2020-07-31","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,915,000,000 United States dollar\", as of 2020-01-24 (until 2020-07-31). Claim clm_E09CA8931836, https://asof.is/claim/clm_E09CA8931836, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/0001613103-20-000007-index.htm.","url":"https://asof.is/claim/clm_E09CA8931836","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,915,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E09CA8931836","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2020, filed 2020-02-28"}},{"date":"2020-02-25","until":"2020-06-17","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,340,166,137 shares\", as of 2020-02-25 (until 2020-06-17). Claim clm_10B51698BD17, https://asof.is/claim/clm_10B51698BD17, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/0001613103-20-000007-index.htm.","url":"https://asof.is/claim/clm_10B51698BD17","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,340,166,137 shares","status":"superseded","assertable":true,"id":"clm_10B51698BD17","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2020, filed 2020-02-28"}},{"date":"2020-04-01","until":null,"published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc ceo: Geoffrey S Martha\", as of 2020-04-01. Claim clm_45B7203AED52, https://asof.is/claim/clm_45B7203AED52, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/mdt-20260424.htm.","url":"https://asof.is/claim/clm_45B7203AED52","accessed":"2026-11-09"},"kind":"people","predicate":"ceo","value":"Geoffrey S Martha","status":"valid","assertable":true,"id":"clm_45B7203AED52","evidence":{"by":"page-read","on":"2026-11-08","quote":"Geoffrey S. Martha , 56 - Chairman of the Board of Directors and Chief Executive Officer Mr. Martha became Chairman of the Board of Directors in December 2020 subsequent to his appointment as Chief Executive Officer in April 2020","url":"https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/mdt-20260424.htm"}},{"date":"2020-04-24","until":"2021-04-30","published":"2020-06-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 28,913,000,000 United States dollar\", as of 2020-04-24 (until 2021-04-30). Claim clm_2A3B86E439F9, https://asof.is/claim/clm_2A3B86E439F9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/0001613103-20-000021-index.htm.","url":"https://asof.is/claim/clm_2A3B86E439F9","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"28,913,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2A3B86E439F9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2020, filed 2020-06-19"}},{"date":"2020-04-24","until":"2020-07-31","published":"2020-06-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,140,000,000 United States dollar\", as of 2020-04-24 (until 2020-07-31). Claim clm_484275AB75BD, https://asof.is/claim/clm_484275AB75BD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/0001613103-20-000021-index.htm.","url":"https://asof.is/claim/clm_484275AB75BD","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,140,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_484275AB75BD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2020, filed 2020-06-19"}},{"date":"2020-04-24","until":"2021-04-30","published":"2020-06-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 4,789,000,000 United States dollar\", as of 2020-04-24 (until 2021-04-30). Claim clm_65226BDA30E9, https://asof.is/claim/clm_65226BDA30E9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/0001613103-20-000021-index.htm.","url":"https://asof.is/claim/clm_65226BDA30E9","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"4,789,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_65226BDA30E9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2020, filed 2020-06-19"}},{"date":"2020-04-24","until":"2020-07-31","published":"2020-06-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,737,000,000 United States dollar\", as of 2020-04-24 (until 2020-07-31). Claim clm_8B6CEF2B55E1, https://asof.is/claim/clm_8B6CEF2B55E1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/0001613103-20-000021-index.htm.","url":"https://asof.is/claim/clm_8B6CEF2B55E1","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,737,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8B6CEF2B55E1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2020, filed 2020-06-19"}},{"date":"2020-04-24","until":"2020-07-31","published":"2020-06-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,689,000,000 United States dollar\", as of 2020-04-24 (until 2020-07-31). Claim clm_8D457927A5B7, https://asof.is/claim/clm_8D457927A5B7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/0001613103-20-000021-index.htm.","url":"https://asof.is/claim/clm_8D457927A5B7","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"90,689,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8D457927A5B7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2020, filed 2020-06-19"}},{"date":"2020-04-24","until":"2021-04-30","published":"2020-06-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 4,791,000,000 United States dollar\", as of 2020-04-24 (until 2021-04-30). Claim clm_BDBAC98C867D, https://asof.is/claim/clm_BDBAC98C867D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/0001613103-20-000021-index.htm.","url":"https://asof.is/claim/clm_BDBAC98C867D","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"4,791,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BDBAC98C867D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2020, filed 2020-06-19"}},{"date":"2020-06-17","until":"2020-09-02","published":"2020-06-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,341,298,882 shares\", as of 2020-06-17 (until 2020-09-02). Claim clm_335651A7E8CD, https://asof.is/claim/clm_335651A7E8CD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/0001613103-20-000021-index.htm.","url":"https://asof.is/claim/clm_335651A7E8CD","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,341,298,882 shares","status":"superseded","assertable":true,"id":"clm_335651A7E8CD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2020, filed 2020-06-19"}},{"date":"2020-07-31","until":"2020-10-30","published":"2020-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,296,000,000 United States dollar\", as of 2020-07-31 (until 2020-10-30). Claim clm_3228B83890C4, https://asof.is/claim/clm_3228B83890C4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000033/0001613103-20-000033-index.htm.","url":"https://asof.is/claim/clm_3228B83890C4","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,296,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3228B83890C4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2021, filed 2020-09-03"}},{"date":"2020-07-31","until":"2020-10-30","published":"2020-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 6,507,000,000 United States dollar\", as of 2020-07-31 (until 2020-10-30). Claim clm_45C9CDBEE989, https://asof.is/claim/clm_45C9CDBEE989, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000033/0001613103-20-000033-index.htm.","url":"https://asof.is/claim/clm_45C9CDBEE989","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"6,507,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_45C9CDBEE989","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2021, filed 2020-09-03"}},{"date":"2020-07-31","until":"2020-10-30","published":"2020-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 487,000,000 United States dollar\", as of 2020-07-31 (until 2020-10-30). Claim clm_5C2596542785, https://asof.is/claim/clm_5C2596542785, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000033/0001613103-20-000033-index.htm.","url":"https://asof.is/claim/clm_5C2596542785","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"487,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5C2596542785","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2021, filed 2020-09-03"}},{"date":"2020-07-31","until":"2020-10-30","published":"2020-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 6,499,000,000 United States dollar\", as of 2020-07-31 (until 2020-10-30). Claim clm_884F4F7D95EB, https://asof.is/claim/clm_884F4F7D95EB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000033/0001613103-20-000033-index.htm.","url":"https://asof.is/claim/clm_884F4F7D95EB","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"6,499,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_884F4F7D95EB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2021, filed 2020-09-03"}},{"date":"2020-07-31","until":"2020-10-30","published":"2020-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 93,906,000,000 United States dollar\", as of 2020-07-31 (until 2020-10-30). Claim clm_8EE9365C87A6, https://asof.is/claim/clm_8EE9365C87A6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000033/0001613103-20-000033-index.htm.","url":"https://asof.is/claim/clm_8EE9365C87A6","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"93,906,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8EE9365C87A6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2021, filed 2020-09-03"}},{"date":"2020-07-31","until":"2020-10-30","published":"2020-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 673,000,000 United States dollar\", as of 2020-07-31 (until 2020-10-30). Claim clm_FD0F5C98C138, https://asof.is/claim/clm_FD0F5C98C138, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000033/0001613103-20-000033-index.htm.","url":"https://asof.is/claim/clm_FD0F5C98C138","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"673,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FD0F5C98C138","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2021, filed 2020-09-03"}},{"date":"2020-09-02","until":"2020-12-01","published":"2020-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,344,215,261 shares\", as of 2020-09-02 (until 2020-12-01). Claim clm_A4D128FD3323, https://asof.is/claim/clm_A4D128FD3323, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000033/0001613103-20-000033-index.htm.","url":"https://asof.is/claim/clm_A4D128FD3323","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,344,215,261 shares","status":"superseded","assertable":true,"id":"clm_A4D128FD3323","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2021, filed 2020-09-03"}},{"date":"2020-10-30","until":"2021-01-29","published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 930,000,000 United States dollar\", as of 2020-10-30 (until 2021-01-29). Claim clm_66AA1731C5F1, https://asof.is/claim/clm_66AA1731C5F1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/0001613103-20-000051-index.htm.","url":"https://asof.is/claim/clm_66AA1731C5F1","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"930,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_66AA1731C5F1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2021, filed 2020-12-03"}},{"date":"2020-10-30","until":"2021-01-29","published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 95,886,000,000 United States dollar\", as of 2020-10-30 (until 2021-01-29). Claim clm_8040F98EE155, https://asof.is/claim/clm_8040F98EE155, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/0001613103-20-000051-index.htm.","url":"https://asof.is/claim/clm_8040F98EE155","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"95,886,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8040F98EE155","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2021, filed 2020-12-03"}},{"date":"2020-10-30","until":"2021-01-29","published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 6,420,000,000 United States dollar\", as of 2020-10-30 (until 2021-01-29). Claim clm_AAEF9893423F, https://asof.is/claim/clm_AAEF9893423F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/0001613103-20-000051-index.htm.","url":"https://asof.is/claim/clm_AAEF9893423F","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"6,420,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AAEF9893423F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2021, filed 2020-12-03"}},{"date":"2020-10-30","until":"2021-01-29","published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,164,000,000 United States dollar\", as of 2020-10-30 (until 2021-01-29). Claim clm_D02E140D3EE8, https://asof.is/claim/clm_D02E140D3EE8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/0001613103-20-000051-index.htm.","url":"https://asof.is/claim/clm_D02E140D3EE8","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,164,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D02E140D3EE8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2021, filed 2020-12-03"}},{"date":"2020-10-30","until":"2021-01-29","published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 489,000,000 United States dollar\", as of 2020-10-30 (until 2021-01-29). Claim clm_E9FBD5EB73A3, https://asof.is/claim/clm_E9FBD5EB73A3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/0001613103-20-000051-index.htm.","url":"https://asof.is/claim/clm_E9FBD5EB73A3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"489,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E9FBD5EB73A3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2021, filed 2020-12-03"}},{"date":"2020-10-30","until":"2021-01-29","published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,647,000,000 United States dollar\", as of 2020-10-30 (until 2021-01-29). Claim clm_F9E042E33CD0, https://asof.is/claim/clm_F9E042E33CD0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/0001613103-20-000051-index.htm.","url":"https://asof.is/claim/clm_F9E042E33CD0","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,647,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F9E042E33CD0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2021, filed 2020-12-03"}},{"date":"2020-12-01","until":null,"published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc chair: Geoffrey S. Martha\", as of 2020-12-01. Claim clm_1479CCC200EC, https://asof.is/claim/clm_1479CCC200EC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/mdt-20260424.htm.","url":"https://asof.is/claim/clm_1479CCC200EC","accessed":"2026-11-09"},"kind":"people","predicate":"chair","value":"Geoffrey S. Martha","status":"valid","assertable":true,"id":"clm_1479CCC200EC","evidence":{"by":"page-read","on":"2026-11-08","quote":"Geoffrey S. Martha , 56 - Chairman of the Board of Directors and Chief Executive Officer Mr. Martha became Chairman of the Board of Directors in December 2020 subsequent to his appointment as Chief Executive Officer in April 2020","url":"https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/mdt-20260424.htm"}},{"date":"2020-12-01","until":"2021-03-03","published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,346,019,949 shares\", as of 2020-12-01 (until 2021-03-03). Claim clm_4A7EBAEF4C94, https://asof.is/claim/clm_4A7EBAEF4C94, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/0001613103-20-000051-index.htm.","url":"https://asof.is/claim/clm_4A7EBAEF4C94","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,346,019,949 shares","status":"superseded","assertable":true,"id":"clm_4A7EBAEF4C94","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2021, filed 2020-12-03"}},{"date":"2021-01-29","until":"2021-04-30","published":"2021-03-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,758,000,000 United States dollar\", as of 2021-01-29 (until 2021-04-30). Claim clm_03AB7E93D87D, https://asof.is/claim/clm_03AB7E93D87D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000009/0001613103-21-000009-index.htm.","url":"https://asof.is/claim/clm_03AB7E93D87D","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,758,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_03AB7E93D87D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2021, filed 2021-03-05"}},{"date":"2021-01-29","until":"2021-04-30","published":"2021-03-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 5,077,000,000 United States dollar\", as of 2021-01-29 (until 2021-04-30). Claim clm_0D06E25043F7, https://asof.is/claim/clm_0D06E25043F7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000009/0001613103-21-000009-index.htm.","url":"https://asof.is/claim/clm_0D06E25043F7","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,077,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0D06E25043F7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2021, filed 2021-03-05"}},{"date":"2021-01-29","until":"2021-07-30","published":"2021-03-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,775,000,000 United States dollar\", as of 2021-01-29 (until 2021-07-30). Claim clm_38D72F3B5EA6, https://asof.is/claim/clm_38D72F3B5EA6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000009/0001613103-21-000009-index.htm.","url":"https://asof.is/claim/clm_38D72F3B5EA6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,775,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_38D72F3B5EA6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2021, filed 2021-03-05"}},{"date":"2021-01-29","until":"2021-07-30","published":"2021-03-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,270,000,000 United States dollar\", as of 2021-01-29 (until 2021-07-30). Claim clm_44AC383E0F66, https://asof.is/claim/clm_44AC383E0F66, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000009/0001613103-21-000009-index.htm.","url":"https://asof.is/claim/clm_44AC383E0F66","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,270,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_44AC383E0F66","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2021, filed 2021-03-05"}},{"date":"2021-01-29","until":"2021-07-30","published":"2021-03-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,277,000,000 United States dollar\", as of 2021-01-29 (until 2021-07-30). Claim clm_E500AE975EE6, https://asof.is/claim/clm_E500AE975EE6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000009/0001613103-21-000009-index.htm.","url":"https://asof.is/claim/clm_E500AE975EE6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,277,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E500AE975EE6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2021, filed 2021-03-05"}},{"date":"2021-01-29","until":"2021-04-30","published":"2021-03-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 97,270,000,000 United States dollar\", as of 2021-01-29 (until 2021-04-30). Claim clm_F0B071700C47, https://asof.is/claim/clm_F0B071700C47, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000009/0001613103-21-000009-index.htm.","url":"https://asof.is/claim/clm_F0B071700C47","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"97,270,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F0B071700C47","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2021, filed 2021-03-05"}},{"date":"2021-03-03","until":"2021-06-23","published":"2021-03-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,348,072,847 shares\", as of 2021-03-03 (until 2021-06-23). Claim clm_B54273B3D0C4, https://asof.is/claim/clm_B54273B3D0C4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000009/0001613103-21-000009-index.htm.","url":"https://asof.is/claim/clm_B54273B3D0C4","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,348,072,847 shares","status":"superseded","assertable":true,"id":"clm_B54273B3D0C4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2021, filed 2021-03-05"}},{"date":"2021-04-30","until":"2022-04-29","published":"2021-06-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 30,117,000,000 United States dollar\", as of 2021-04-30 (until 2022-04-29). Claim clm_21F5424C6FF7, https://asof.is/claim/clm_21F5424C6FF7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000027/0001613103-21-000027-index.htm.","url":"https://asof.is/claim/clm_21F5424C6FF7","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"30,117,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_21F5424C6FF7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2021, filed 2021-06-25"}},{"date":"2021-04-30","until":"2021-07-30","published":"2021-06-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,593,000,000 United States dollar\", as of 2021-04-30 (until 2021-07-30). Claim clm_9C67FE84B8F8, https://asof.is/claim/clm_9C67FE84B8F8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000027/0001613103-21-000027-index.htm.","url":"https://asof.is/claim/clm_9C67FE84B8F8","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,593,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9C67FE84B8F8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2021, filed 2021-06-25"}},{"date":"2021-04-30","until":"2021-07-30","published":"2021-06-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 93,083,000,000 United States dollar\", as of 2021-04-30 (until 2021-07-30). Claim clm_AA80913D2DAA, https://asof.is/claim/clm_AA80913D2DAA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000027/0001613103-21-000027-index.htm.","url":"https://asof.is/claim/clm_AA80913D2DAA","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"93,083,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AA80913D2DAA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2021, filed 2021-06-25"}},{"date":"2021-04-30","until":"2022-04-29","published":"2021-06-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 3,606,000,000 United States dollar\", as of 2021-04-30 (until 2022-04-29). Claim clm_CCCAA272438C, https://asof.is/claim/clm_CCCAA272438C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000027/0001613103-21-000027-index.htm.","url":"https://asof.is/claim/clm_CCCAA272438C","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"3,606,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CCCAA272438C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2021, filed 2021-06-25"}},{"date":"2021-04-30","until":"2021-07-30","published":"2021-06-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,428,000,000 United States dollar\", as of 2021-04-30 (until 2021-07-30). Claim clm_D4B8B943B869, https://asof.is/claim/clm_D4B8B943B869, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000027/0001613103-21-000027-index.htm.","url":"https://asof.is/claim/clm_D4B8B943B869","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"51,428,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D4B8B943B869","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2021, filed 2021-06-25"}},{"date":"2021-04-30","until":"2022-04-29","published":"2021-06-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 4,484,000,000 United States dollar\", as of 2021-04-30 (until 2022-04-29). Claim clm_ED09BC393B75, https://asof.is/claim/clm_ED09BC393B75, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000027/0001613103-21-000027-index.htm.","url":"https://asof.is/claim/clm_ED09BC393B75","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"4,484,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ED09BC393B75","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2021, filed 2021-06-25"}},{"date":"2021-06-23","until":"2021-08-31","published":"2021-06-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,343,904,180 shares\", as of 2021-06-23 (until 2021-08-31). Claim clm_90B6B6323F33, https://asof.is/claim/clm_90B6B6323F33, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000027/0001613103-21-000027-index.htm.","url":"https://asof.is/claim/clm_90B6B6323F33","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,343,904,180 shares","status":"superseded","assertable":true,"id":"clm_90B6B6323F33","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2021, filed 2021-06-25"}},{"date":"2021-07-30","until":"2021-10-29","published":"2021-09-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,802,000,000 United States dollar\", as of 2021-07-30 (until 2021-10-29). Claim clm_0751291776A2, https://asof.is/claim/clm_0751291776A2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000042/0001613103-21-000042-index.htm.","url":"https://asof.is/claim/clm_0751291776A2","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"91,802,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0751291776A2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2022, filed 2021-09-02"}},{"date":"2021-07-30","until":"2021-10-29","published":"2021-09-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,486,000,000 United States dollar\", as of 2021-07-30 (until 2021-10-29). Claim clm_0B560A208E2D, https://asof.is/claim/clm_0B560A208E2D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000042/0001613103-21-000042-index.htm.","url":"https://asof.is/claim/clm_0B560A208E2D","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"51,486,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0B560A208E2D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2022, filed 2021-09-02"}},{"date":"2021-07-30","until":"2021-10-29","published":"2021-09-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 859,000,000 United States dollar\", as of 2021-07-30 (until 2021-10-29). Claim clm_4341937231AF, https://asof.is/claim/clm_4341937231AF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000042/0001613103-21-000042-index.htm.","url":"https://asof.is/claim/clm_4341937231AF","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"859,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4341937231AF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2022, filed 2021-09-02"}},{"date":"2021-07-30","until":"2021-10-29","published":"2021-09-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 763,000,000 United States dollar\", as of 2021-07-30 (until 2021-10-29). Claim clm_ACA68B2970C3, https://asof.is/claim/clm_ACA68B2970C3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000042/0001613103-21-000042-index.htm.","url":"https://asof.is/claim/clm_ACA68B2970C3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"763,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ACA68B2970C3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2022, filed 2021-09-02"}},{"date":"2021-07-30","until":"2021-10-29","published":"2021-09-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,004,000,000 United States dollar\", as of 2021-07-30 (until 2021-10-29). Claim clm_ACE13439B12D, https://asof.is/claim/clm_ACE13439B12D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000042/0001613103-21-000042-index.htm.","url":"https://asof.is/claim/clm_ACE13439B12D","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,004,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ACE13439B12D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2022, filed 2021-09-02"}},{"date":"2021-07-30","until":"2021-10-29","published":"2021-09-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,987,000,000 United States dollar\", as of 2021-07-30 (until 2021-10-29). Claim clm_B8688FDDE21E, https://asof.is/claim/clm_B8688FDDE21E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000042/0001613103-21-000042-index.htm.","url":"https://asof.is/claim/clm_B8688FDDE21E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,987,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B8688FDDE21E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2022, filed 2021-09-02"}},{"date":"2021-08-31","until":"2021-11-30","published":"2021-09-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,345,809,975 shares\", as of 2021-08-31 (until 2021-11-30). Claim clm_82E3523793B9, https://asof.is/claim/clm_82E3523793B9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000042/0001613103-21-000042-index.htm.","url":"https://asof.is/claim/clm_82E3523793B9","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,345,809,975 shares","status":"superseded","assertable":true,"id":"clm_82E3523793B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2022, filed 2021-09-02"}},{"date":"2021-10-29","until":"2022-01-28","published":"2021-12-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,847,000,000 United States dollar\", as of 2021-10-29 (until 2022-01-28). Claim clm_084EC07CD31E, https://asof.is/claim/clm_084EC07CD31E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000062/0001613103-21-000062-index.htm.","url":"https://asof.is/claim/clm_084EC07CD31E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,847,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_084EC07CD31E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2022, filed 2021-12-02"}},{"date":"2021-10-29","until":"2022-01-28","published":"2021-12-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,311,000,000 United States dollar\", as of 2021-10-29 (until 2022-01-28). Claim clm_16560E6520F1, https://asof.is/claim/clm_16560E6520F1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000062/0001613103-21-000062-index.htm.","url":"https://asof.is/claim/clm_16560E6520F1","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,311,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_16560E6520F1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2022, filed 2021-12-02"}},{"date":"2021-10-29","until":"2022-01-28","published":"2021-12-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,991,000,000 United States dollar\", as of 2021-10-29 (until 2022-01-28). Claim clm_4CE22B5BFD44, https://asof.is/claim/clm_4CE22B5BFD44, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000062/0001613103-21-000062-index.htm.","url":"https://asof.is/claim/clm_4CE22B5BFD44","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"51,991,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4CE22B5BFD44","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2022, filed 2021-12-02"}},{"date":"2021-10-29","until":"2022-01-28","published":"2021-12-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,563,000,000 United States dollar\", as of 2021-10-29 (until 2022-01-28). Claim clm_57424C88BD39, https://asof.is/claim/clm_57424C88BD39, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000062/0001613103-21-000062-index.htm.","url":"https://asof.is/claim/clm_57424C88BD39","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,563,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_57424C88BD39","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2022, filed 2021-12-02"}},{"date":"2021-10-29","until":"2022-01-28","published":"2021-12-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,756,000,000 United States dollar\", as of 2021-10-29 (until 2022-01-28). Claim clm_66FCE253BCC7, https://asof.is/claim/clm_66FCE253BCC7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000062/0001613103-21-000062-index.htm.","url":"https://asof.is/claim/clm_66FCE253BCC7","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"91,756,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_66FCE253BCC7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2022, filed 2021-12-02"}},{"date":"2021-10-29","until":"2022-01-28","published":"2021-12-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,900,000,000 United States dollar\", as of 2021-10-29 (until 2022-01-28). Claim clm_B445A3C2B567, https://asof.is/claim/clm_B445A3C2B567, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000062/0001613103-21-000062-index.htm.","url":"https://asof.is/claim/clm_B445A3C2B567","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,900,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B445A3C2B567","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2022, filed 2021-12-02"}},{"date":"2021-11-30","until":"2022-03-01","published":"2021-12-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,344,557,784 shares\", as of 2021-11-30 (until 2022-03-01). Claim clm_64EFE67007EA, https://asof.is/claim/clm_64EFE67007EA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000062/0001613103-21-000062-index.htm.","url":"https://asof.is/claim/clm_64EFE67007EA","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,344,557,784 shares","status":"superseded","assertable":true,"id":"clm_64EFE67007EA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2022, filed 2021-12-02"}},{"date":"2022-01-28","until":"2022-04-29","published":"2022-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 52,542,000,000 United States dollar\", as of 2022-01-28 (until 2022-04-29). Claim clm_0066321BEAA2, https://asof.is/claim/clm_0066321BEAA2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/0001613103-22-000011-index.htm.","url":"https://asof.is/claim/clm_0066321BEAA2","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"52,542,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0066321BEAA2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2022, filed 2022-03-03"}},{"date":"2022-01-28","until":"2022-07-29","published":"2022-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,763,000,000 United States dollar\", as of 2022-01-28 (until 2022-07-29). Claim clm_1800FF129C25, https://asof.is/claim/clm_1800FF129C25, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/0001613103-22-000011-index.htm.","url":"https://asof.is/claim/clm_1800FF129C25","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,763,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1800FF129C25","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2022, filed 2022-03-03"}},{"date":"2022-01-28","until":"2022-07-29","published":"2022-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,480,000,000 United States dollar\", as of 2022-01-28 (until 2022-07-29). Claim clm_449010394AB6, https://asof.is/claim/clm_449010394AB6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/0001613103-22-000011-index.htm.","url":"https://asof.is/claim/clm_449010394AB6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,480,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_449010394AB6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2022, filed 2022-03-03"}},{"date":"2022-01-28","until":"2022-04-29","published":"2022-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,804,000,000 United States dollar\", as of 2022-01-28 (until 2022-04-29). Claim clm_61E60749CAE9, https://asof.is/claim/clm_61E60749CAE9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/0001613103-22-000011-index.htm.","url":"https://asof.is/claim/clm_61E60749CAE9","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"91,804,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_61E60749CAE9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2022, filed 2022-03-03"}},{"date":"2022-01-28","until":"2022-04-29","published":"2022-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,479,000,000 United States dollar\", as of 2022-01-28 (until 2022-04-29). Claim clm_7873CBD8572E, https://asof.is/claim/clm_7873CBD8572E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/0001613103-22-000011-index.htm.","url":"https://asof.is/claim/clm_7873CBD8572E","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,479,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7873CBD8572E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2022, filed 2022-03-03"}},{"date":"2022-01-28","until":"2022-07-29","published":"2022-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,659,000,000 United States dollar\", as of 2022-01-28 (until 2022-07-29). Claim clm_9CBE4B5CE8EE, https://asof.is/claim/clm_9CBE4B5CE8EE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/0001613103-22-000011-index.htm.","url":"https://asof.is/claim/clm_9CBE4B5CE8EE","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,659,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9CBE4B5CE8EE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2022, filed 2022-03-03"}},{"date":"2022-03-01","until":"2022-06-20","published":"2022-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,341,539,178 shares\", as of 2022-03-01 (until 2022-06-20). Claim clm_463D688AE5CD, https://asof.is/claim/clm_463D688AE5CD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/0001613103-22-000011-index.htm.","url":"https://asof.is/claim/clm_463D688AE5CD","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,341,539,178 shares","status":"superseded","assertable":true,"id":"clm_463D688AE5CD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2022, filed 2022-03-03"}},{"date":"2022-04-29","until":"2023-04-28","published":"2022-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 31,686,000,000 United States dollar\", as of 2022-04-29 (until 2023-04-28). Claim clm_43D2691A3614, https://asof.is/claim/clm_43D2691A3614, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000023/0001613103-22-000023-index.htm.","url":"https://asof.is/claim/clm_43D2691A3614","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"31,686,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_43D2691A3614","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2022, filed 2022-06-23"}},{"date":"2022-04-29","until":"2022-07-29","published":"2022-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,714,000,000 United States dollar\", as of 2022-04-29 (until 2022-07-29). Claim clm_694E6E2BE37F, https://asof.is/claim/clm_694E6E2BE37F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000023/0001613103-22-000023-index.htm.","url":"https://asof.is/claim/clm_694E6E2BE37F","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,714,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_694E6E2BE37F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2022, filed 2022-06-23"}},{"date":"2022-04-29","until":"2023-04-28","published":"2022-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 5,752,000,000 United States dollar\", as of 2022-04-29 (until 2023-04-28). Claim clm_810EE4D11948, https://asof.is/claim/clm_810EE4D11948, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000023/0001613103-22-000023-index.htm.","url":"https://asof.is/claim/clm_810EE4D11948","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"5,752,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_810EE4D11948","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2022, filed 2022-06-23"}},{"date":"2022-04-29","until":"2023-04-28","published":"2022-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 5,039,000,000 United States dollar\", as of 2022-04-29 (until 2023-04-28). Claim clm_8F034BEA8363, https://asof.is/claim/clm_8F034BEA8363, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000023/0001613103-22-000023-index.htm.","url":"https://asof.is/claim/clm_8F034BEA8363","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"5,039,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8F034BEA8363","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2022, filed 2022-06-23"}},{"date":"2022-04-29","until":"2022-07-29","published":"2022-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 52,551,000,000 United States dollar\", as of 2022-04-29 (until 2022-07-29). Claim clm_9F194A99A41C, https://asof.is/claim/clm_9F194A99A41C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000023/0001613103-22-000023-index.htm.","url":"https://asof.is/claim/clm_9F194A99A41C","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"52,551,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9F194A99A41C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2022, filed 2022-06-23"}},{"date":"2022-04-29","until":"2022-07-29","published":"2022-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,981,000,000 United States dollar\", as of 2022-04-29 (until 2022-07-29). Claim clm_FC280FE9F1F9, https://asof.is/claim/clm_FC280FE9F1F9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000023/0001613103-22-000023-index.htm.","url":"https://asof.is/claim/clm_FC280FE9F1F9","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"90,981,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FC280FE9F1F9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2022, filed 2022-06-23"}},{"date":"2022-06-20","until":"2022-08-29","published":"2022-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,328,709,310 shares\", as of 2022-06-20 (until 2022-08-29). Claim clm_B630217AE90C, https://asof.is/claim/clm_B630217AE90C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000023/0001613103-22-000023-index.htm.","url":"https://asof.is/claim/clm_B630217AE90C","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,328,709,310 shares","status":"superseded","assertable":true,"id":"clm_B630217AE90C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2022, filed 2022-06-23"}},{"date":"2022-07-29","until":"2022-10-28","published":"2022-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 89,914,000,000 United States dollar\", as of 2022-07-29 (until 2022-10-28). Claim clm_0EB9275AF24B, https://asof.is/claim/clm_0EB9275AF24B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000046/0001613103-22-000046-index.htm.","url":"https://asof.is/claim/clm_0EB9275AF24B","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"89,914,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0EB9275AF24B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2023, filed 2022-09-01"}},{"date":"2022-07-29","until":"2022-10-28","published":"2022-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,125,000,000 United States dollar\", as of 2022-07-29 (until 2022-10-28). Claim clm_2EEA422F485E, https://asof.is/claim/clm_2EEA422F485E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000046/0001613103-22-000046-index.htm.","url":"https://asof.is/claim/clm_2EEA422F485E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,125,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2EEA422F485E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2023, filed 2022-09-01"}},{"date":"2022-07-29","until":"2022-10-28","published":"2022-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 929,000,000 United States dollar\", as of 2022-07-29 (until 2022-10-28). Claim clm_3DDF91D057BF, https://asof.is/claim/clm_3DDF91D057BF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000046/0001613103-22-000046-index.htm.","url":"https://asof.is/claim/clm_3DDF91D057BF","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"929,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3DDF91D057BF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2023, filed 2022-09-01"}},{"date":"2022-07-29","until":"2022-10-28","published":"2022-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,371,000,000 United States dollar\", as of 2022-07-29 (until 2022-10-28). Claim clm_9A95F4D87E7E, https://asof.is/claim/clm_9A95F4D87E7E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000046/0001613103-22-000046-index.htm.","url":"https://asof.is/claim/clm_9A95F4D87E7E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,371,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9A95F4D87E7E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2023, filed 2022-09-01"}},{"date":"2022-07-29","until":"2022-10-28","published":"2022-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,140,000,000 United States dollar\", as of 2022-07-29 (until 2022-10-28). Claim clm_9B46D6B85D39, https://asof.is/claim/clm_9B46D6B85D39, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000046/0001613103-22-000046-index.htm.","url":"https://asof.is/claim/clm_9B46D6B85D39","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,140,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9B46D6B85D39","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2023, filed 2022-09-01"}},{"date":"2022-07-29","until":"2022-10-28","published":"2022-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 52,672,000,000 United States dollar\", as of 2022-07-29 (until 2022-10-28). Claim clm_DD40A12043A7, https://asof.is/claim/clm_DD40A12043A7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000046/0001613103-22-000046-index.htm.","url":"https://asof.is/claim/clm_DD40A12043A7","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"52,672,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DD40A12043A7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2023, filed 2022-09-01"}},{"date":"2022-08-29","until":"2022-11-28","published":"2022-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,329,153,289 shares\", as of 2022-08-29 (until 2022-11-28). Claim clm_2CAEB4A02916, https://asof.is/claim/clm_2CAEB4A02916, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000046/0001613103-22-000046-index.htm.","url":"https://asof.is/claim/clm_2CAEB4A02916","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,329,153,289 shares","status":"superseded","assertable":true,"id":"clm_2CAEB4A02916","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2023, filed 2022-09-01"}},{"date":"2022-10-28","until":"2023-01-27","published":"2022-12-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,880,000,000 United States dollar\", as of 2022-10-28 (until 2023-01-27). Claim clm_1279FA519D7B, https://asof.is/claim/clm_1279FA519D7B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000063/0001613103-22-000063-index.htm.","url":"https://asof.is/claim/clm_1279FA519D7B","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"51,880,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1279FA519D7B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2023, filed 2022-12-01"}},{"date":"2022-10-28","until":"2023-01-27","published":"2022-12-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,404,000,000 United States dollar\", as of 2022-10-28 (until 2023-01-27). Claim clm_3C00CAE57B29, https://asof.is/claim/clm_3C00CAE57B29, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000063/0001613103-22-000063-index.htm.","url":"https://asof.is/claim/clm_3C00CAE57B29","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,404,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3C00CAE57B29","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2023, filed 2022-12-01"}},{"date":"2022-10-28","until":"2023-01-27","published":"2022-12-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,585,000,000 United States dollar\", as of 2022-10-28 (until 2023-01-27). Claim clm_4ED13BF01446, https://asof.is/claim/clm_4ED13BF01446, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000063/0001613103-22-000063-index.htm.","url":"https://asof.is/claim/clm_4ED13BF01446","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,585,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4ED13BF01446","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2023, filed 2022-12-01"}},{"date":"2022-10-28","until":"2023-01-27","published":"2022-12-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 93,241,000,000 United States dollar\", as of 2022-10-28 (until 2023-01-27). Claim clm_5B9B829E7019, https://asof.is/claim/clm_5B9B829E7019, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000063/0001613103-22-000063-index.htm.","url":"https://asof.is/claim/clm_5B9B829E7019","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"93,241,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5B9B829E7019","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2023, filed 2022-12-01"}},{"date":"2022-10-28","until":"2023-01-27","published":"2022-12-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 427,000,000 United States dollar\", as of 2022-10-28 (until 2023-01-27). Claim clm_B6FEA1E7091A, https://asof.is/claim/clm_B6FEA1E7091A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000063/0001613103-22-000063-index.htm.","url":"https://asof.is/claim/clm_B6FEA1E7091A","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"427,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B6FEA1E7091A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2023, filed 2022-12-01"}},{"date":"2022-10-28","until":"2023-01-27","published":"2022-12-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,828,000,000 United States dollar\", as of 2022-10-28 (until 2023-01-27). Claim clm_E3E18401576F, https://asof.is/claim/clm_E3E18401576F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000063/0001613103-22-000063-index.htm.","url":"https://asof.is/claim/clm_E3E18401576F","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,828,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E3E18401576F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2023, filed 2022-12-01"}},{"date":"2022-11-28","until":"2023-02-27","published":"2022-12-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,330,179,978 shares\", as of 2022-11-28 (until 2023-02-27). Claim clm_F47F14CDCCC3, https://asof.is/claim/clm_F47F14CDCCC3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000063/0001613103-22-000063-index.htm.","url":"https://asof.is/claim/clm_F47F14CDCCC3","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,330,179,978 shares","status":"superseded","assertable":true,"id":"clm_F47F14CDCCC3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2023, filed 2022-12-01"}},{"date":"2023-01-27","until":"2023-07-28","published":"2023-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,222,000,000 United States dollar\", as of 2023-01-27 (until 2023-07-28). Claim clm_1C24082D315D, https://asof.is/claim/clm_1C24082D315D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/0001613103-23-000008-index.htm.","url":"https://asof.is/claim/clm_1C24082D315D","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,222,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1C24082D315D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2023, filed 2023-03-01"}},{"date":"2023-01-27","until":"2023-07-28","published":"2023-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,727,000,000 United States dollar\", as of 2023-01-27 (until 2023-07-28). Claim clm_6E25782CF337, https://asof.is/claim/clm_6E25782CF337, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/0001613103-23-000008-index.htm.","url":"https://asof.is/claim/clm_6E25782CF337","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,727,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6E25782CF337","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2023, filed 2023-03-01"}},{"date":"2023-01-27","until":"2023-04-28","published":"2023-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,521,000,000 United States dollar\", as of 2023-01-27 (until 2023-04-28). Claim clm_766C3665AD97, https://asof.is/claim/clm_766C3665AD97, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/0001613103-23-000008-index.htm.","url":"https://asof.is/claim/clm_766C3665AD97","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,521,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_766C3665AD97","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2023, filed 2023-03-01"}},{"date":"2023-01-27","until":"2023-07-28","published":"2023-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,392,000,000 United States dollar\", as of 2023-01-27 (until 2023-07-28). Claim clm_BD5B3AFA2F2E, https://asof.is/claim/clm_BD5B3AFA2F2E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/0001613103-23-000008-index.htm.","url":"https://asof.is/claim/clm_BD5B3AFA2F2E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,392,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BD5B3AFA2F2E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2023, filed 2023-03-01"}},{"date":"2023-01-27","until":"2023-04-28","published":"2023-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 94,134,000,000 United States dollar\", as of 2023-01-27 (until 2023-04-28). Claim clm_DD2BDC126321, https://asof.is/claim/clm_DD2BDC126321, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/0001613103-23-000008-index.htm.","url":"https://asof.is/claim/clm_DD2BDC126321","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"94,134,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DD2BDC126321","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2023, filed 2023-03-01"}},{"date":"2023-01-27","until":"2023-04-28","published":"2023-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,441,000,000 United States dollar\", as of 2023-01-27 (until 2023-04-28). Claim clm_EE889E63DD40, https://asof.is/claim/clm_EE889E63DD40, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/0001613103-23-000008-index.htm.","url":"https://asof.is/claim/clm_EE889E63DD40","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"51,441,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EE889E63DD40","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2023, filed 2023-03-01"}},{"date":"2023-02-27","until":"2023-06-16","published":"2023-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,330,423,708 shares\", as of 2023-02-27 (until 2023-06-16). Claim clm_151766BAADC7, https://asof.is/claim/clm_151766BAADC7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/0001613103-23-000008-index.htm.","url":"https://asof.is/claim/clm_151766BAADC7","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,330,423,708 shares","status":"superseded","assertable":true,"id":"clm_151766BAADC7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2023, filed 2023-03-01"}},{"date":"2023-04-28","until":"2024-04-26","published":"2023-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 3,758,000,000 United States dollar\", as of 2023-04-28 (until 2024-04-26). Claim clm_23B51D64A953, https://asof.is/claim/clm_23B51D64A953, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/0001613103-23-000040-index.htm.","url":"https://asof.is/claim/clm_23B51D64A953","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"3,758,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_23B51D64A953","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2023, filed 2023-06-22"}},{"date":"2023-04-28","until":"2023-07-28","published":"2023-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,948,000,000 United States dollar\", as of 2023-04-28 (until 2023-07-28). Claim clm_8B42B813BE0A, https://asof.is/claim/clm_8B42B813BE0A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/0001613103-23-000040-index.htm.","url":"https://asof.is/claim/clm_8B42B813BE0A","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"90,948,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8B42B813BE0A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2023, filed 2023-06-22"}},{"date":"2023-04-28","until":"2024-04-26","published":"2023-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 5,485,000,000 United States dollar\", as of 2023-04-28 (until 2024-04-26). Claim clm_95AC1EAE0F90, https://asof.is/claim/clm_95AC1EAE0F90, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/0001613103-23-000040-index.htm.","url":"https://asof.is/claim/clm_95AC1EAE0F90","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"5,485,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_95AC1EAE0F90","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2023, filed 2023-06-22"}},{"date":"2023-04-28","until":"2023-07-28","published":"2023-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,483,000,000 United States dollar\", as of 2023-04-28 (until 2023-07-28). Claim clm_B7A3916E07AD, https://asof.is/claim/clm_B7A3916E07AD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/0001613103-23-000040-index.htm.","url":"https://asof.is/claim/clm_B7A3916E07AD","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"51,483,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B7A3916E07AD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2023, filed 2023-06-22"}},{"date":"2023-04-28","until":"2024-04-26","published":"2023-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 31,227,000,000 United States dollar\", as of 2023-04-28 (until 2024-04-26). Claim clm_DA0C7A0FA0B8, https://asof.is/claim/clm_DA0C7A0FA0B8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/0001613103-23-000040-index.htm.","url":"https://asof.is/claim/clm_DA0C7A0FA0B8","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"31,227,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DA0C7A0FA0B8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2023, filed 2023-06-22"}},{"date":"2023-04-28","until":"2023-07-28","published":"2023-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,543,000,000 United States dollar\", as of 2023-04-28 (until 2023-07-28). Claim clm_FB0842C0C0B2, https://asof.is/claim/clm_FB0842C0C0B2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/0001613103-23-000040-index.htm.","url":"https://asof.is/claim/clm_FB0842C0C0B2","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,543,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FB0842C0C0B2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2023, filed 2023-06-22"}},{"date":"2023-06-16","until":"2023-08-25","published":"2023-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,330,405,428 shares\", as of 2023-06-16 (until 2023-08-25). Claim clm_87D3A4BAB877, https://asof.is/claim/clm_87D3A4BAB877, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/0001613103-23-000040-index.htm.","url":"https://asof.is/claim/clm_87D3A4BAB877","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,330,405,428 shares","status":"superseded","assertable":true,"id":"clm_87D3A4BAB877","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2023, filed 2023-06-22"}},{"date":"2023-07-28","until":"2023-10-27","published":"2023-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,702,000,000 United States dollar\", as of 2023-07-28 (until 2023-10-27). Claim clm_2BA3F1974C73, https://asof.is/claim/clm_2BA3F1974C73, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/0001613103-23-000128-index.htm.","url":"https://asof.is/claim/clm_2BA3F1974C73","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,702,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2BA3F1974C73","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2024, filed 2023-08-31"}},{"date":"2023-07-28","until":"2023-10-27","published":"2023-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,268,000,000 United States dollar\", as of 2023-07-28 (until 2023-10-27). Claim clm_A31F28636071, https://asof.is/claim/clm_A31F28636071, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/0001613103-23-000128-index.htm.","url":"https://asof.is/claim/clm_A31F28636071","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,268,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A31F28636071","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2024, filed 2023-08-31"}},{"date":"2023-07-28","until":"2023-10-27","published":"2023-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,339,000,000 United States dollar\", as of 2023-07-28 (until 2023-10-27). Claim clm_B931396F2157, https://asof.is/claim/clm_B931396F2157, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/0001613103-23-000128-index.htm.","url":"https://asof.is/claim/clm_B931396F2157","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,339,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B931396F2157","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2024, filed 2023-08-31"}},{"date":"2023-07-28","until":"2023-10-27","published":"2023-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,776,000,000 United States dollar\", as of 2023-07-28 (until 2023-10-27). Claim clm_C357DDC988BA, https://asof.is/claim/clm_C357DDC988BA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/0001613103-23-000128-index.htm.","url":"https://asof.is/claim/clm_C357DDC988BA","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"90,776,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C357DDC988BA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2024, filed 2023-08-31"}},{"date":"2023-07-28","until":"2023-10-27","published":"2023-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,178,000,000 United States dollar\", as of 2023-07-28 (until 2023-10-27). Claim clm_DADE47B7DD6C, https://asof.is/claim/clm_DADE47B7DD6C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/0001613103-23-000128-index.htm.","url":"https://asof.is/claim/clm_DADE47B7DD6C","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"51,178,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DADE47B7DD6C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2024, filed 2023-08-31"}},{"date":"2023-07-28","until":"2023-10-27","published":"2023-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 791,000,000 United States dollar\", as of 2023-07-28 (until 2023-10-27). Claim clm_E61E5B826FDE, https://asof.is/claim/clm_E61E5B826FDE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/0001613103-23-000128-index.htm.","url":"https://asof.is/claim/clm_E61E5B826FDE","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"791,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E61E5B826FDE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2024, filed 2023-08-31"}},{"date":"2023-08-25","until":"2023-11-24","published":"2023-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,330,533,713 shares\", as of 2023-08-25 (until 2023-11-24). Claim clm_ABCDBF642530, https://asof.is/claim/clm_ABCDBF642530, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/0001613103-23-000128-index.htm.","url":"https://asof.is/claim/clm_ABCDBF642530","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,330,533,713 shares","status":"superseded","assertable":true,"id":"clm_ABCDBF642530","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2024, filed 2023-08-31"}},{"date":"2023-10-27","until":"2024-01-26","published":"2023-11-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,311,000,000 United States dollar\", as of 2023-10-27 (until 2024-01-26). Claim clm_1CBD207D0426, https://asof.is/claim/clm_1CBD207D0426, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000149/0001613103-23-000149-index.htm.","url":"https://asof.is/claim/clm_1CBD207D0426","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,311,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1CBD207D0426","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2024, filed 2023-11-30"}},{"date":"2023-10-27","until":"2024-01-26","published":"2023-11-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 909,000,000 United States dollar\", as of 2023-10-27 (until 2024-01-26). Claim clm_42CF26AE1CBA, https://asof.is/claim/clm_42CF26AE1CBA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000149/0001613103-23-000149-index.htm.","url":"https://asof.is/claim/clm_42CF26AE1CBA","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"909,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_42CF26AE1CBA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2024, filed 2023-11-30"}},{"date":"2023-10-27","until":"2024-01-26","published":"2023-11-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,087,000,000 United States dollar\", as of 2023-10-27 (until 2024-01-26). Claim clm_5961178F7EA2, https://asof.is/claim/clm_5961178F7EA2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000149/0001613103-23-000149-index.htm.","url":"https://asof.is/claim/clm_5961178F7EA2","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"90,087,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5961178F7EA2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2024, filed 2023-11-30"}},{"date":"2023-10-27","until":"2024-01-26","published":"2023-11-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,340,000,000 United States dollar\", as of 2023-10-27 (until 2024-01-26). Claim clm_63778B6299A3, https://asof.is/claim/clm_63778B6299A3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000149/0001613103-23-000149-index.htm.","url":"https://asof.is/claim/clm_63778B6299A3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,340,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_63778B6299A3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2024, filed 2023-11-30"}},{"date":"2023-10-27","until":"2024-01-26","published":"2023-11-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,460,000,000 United States dollar\", as of 2023-10-27 (until 2024-01-26). Claim clm_84AE3E6E2ED1, https://asof.is/claim/clm_84AE3E6E2ED1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000149/0001613103-23-000149-index.htm.","url":"https://asof.is/claim/clm_84AE3E6E2ED1","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"51,460,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_84AE3E6E2ED1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2024, filed 2023-11-30"}},{"date":"2023-10-27","until":"2024-01-26","published":"2023-11-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,984,000,000 United States dollar\", as of 2023-10-27 (until 2024-01-26). Claim clm_9D652E2083D2, https://asof.is/claim/clm_9D652E2083D2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000149/0001613103-23-000149-index.htm.","url":"https://asof.is/claim/clm_9D652E2083D2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,984,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9D652E2083D2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2024, filed 2023-11-30"}},{"date":"2023-11-24","until":"2024-02-21","published":"2023-11-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,329,654,311 shares\", as of 2023-11-24 (until 2024-02-21). Claim clm_335F7D1CEB89, https://asof.is/claim/clm_335F7D1CEB89, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000149/0001613103-23-000149-index.htm.","url":"https://asof.is/claim/clm_335F7D1CEB89","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,329,654,311 shares","status":"superseded","assertable":true,"id":"clm_335F7D1CEB89","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2024, filed 2023-11-30"}},{"date":"2024-01-26","until":"2024-07-26","published":"2024-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,322,000,000 United States dollar\", as of 2024-01-26 (until 2024-07-26). Claim clm_07DDB710D198, https://asof.is/claim/clm_07DDB710D198, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000011/0001613103-24-000011-index.htm.","url":"https://asof.is/claim/clm_07DDB710D198","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,322,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_07DDB710D198","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2024, filed 2024-02-27"}},{"date":"2024-01-26","until":"2024-07-26","published":"2024-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 8,089,000,000 United States dollar\", as of 2024-01-26 (until 2024-07-26). Claim clm_161694F7F265, https://asof.is/claim/clm_161694F7F265, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000011/0001613103-24-000011-index.htm.","url":"https://asof.is/claim/clm_161694F7F265","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"8,089,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_161694F7F265","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2024, filed 2024-02-27"}},{"date":"2024-01-26","until":"2024-04-26","published":"2024-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,792,000,000 United States dollar\", as of 2024-01-26 (until 2024-04-26). Claim clm_4B788EE97A6A, https://asof.is/claim/clm_4B788EE97A6A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000011/0001613103-24-000011-index.htm.","url":"https://asof.is/claim/clm_4B788EE97A6A","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"51,792,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4B788EE97A6A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2024, filed 2024-02-27"}},{"date":"2024-01-26","until":"2024-04-26","published":"2024-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,623,000,000 United States dollar\", as of 2024-01-26 (until 2024-04-26). Claim clm_653A6EBCA64D, https://asof.is/claim/clm_653A6EBCA64D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000011/0001613103-24-000011-index.htm.","url":"https://asof.is/claim/clm_653A6EBCA64D","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,623,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_653A6EBCA64D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2024, filed 2024-02-27"}},{"date":"2024-01-26","until":"2024-07-26","published":"2024-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,483,000,000 United States dollar\", as of 2024-01-26 (until 2024-07-26). Claim clm_A0F94B567CF7, https://asof.is/claim/clm_A0F94B567CF7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000011/0001613103-24-000011-index.htm.","url":"https://asof.is/claim/clm_A0F94B567CF7","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,483,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A0F94B567CF7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2024, filed 2024-02-27"}},{"date":"2024-01-26","until":"2024-04-26","published":"2024-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,836,000,000 United States dollar\", as of 2024-01-26 (until 2024-04-26). Claim clm_D9E0B3C3EFD5, https://asof.is/claim/clm_D9E0B3C3EFD5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000011/0001613103-24-000011-index.htm.","url":"https://asof.is/claim/clm_D9E0B3C3EFD5","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"90,836,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D9E0B3C3EFD5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2024, filed 2024-02-27"}},{"date":"2024-02-21","until":"2024-06-17","published":"2024-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,327,822,539 shares\", as of 2024-02-21 (until 2024-06-17). Claim clm_B3A3C81B0783, https://asof.is/claim/clm_B3A3C81B0783, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000011/0001613103-24-000011-index.htm.","url":"https://asof.is/claim/clm_B3A3C81B0783","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,327,822,539 shares","status":"superseded","assertable":true,"id":"clm_B3A3C81B0783","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2024, filed 2024-02-27"}},{"date":"2024-04-26","until":"2024-07-26","published":"2024-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,284,000,000 United States dollar\", as of 2024-04-26 (until 2024-07-26). Claim clm_600621FE3E89, https://asof.is/claim/clm_600621FE3E89, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000072/0001613103-24-000072-index.htm.","url":"https://asof.is/claim/clm_600621FE3E89","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,284,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_600621FE3E89","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2024, filed 2024-06-20"}},{"date":"2024-04-26","until":"2024-07-26","published":"2024-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 89,981,000,000 United States dollar\", as of 2024-04-26 (until 2024-07-26). Claim clm_6ACEB375E090, https://asof.is/claim/clm_6ACEB375E090, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000072/0001613103-24-000072-index.htm.","url":"https://asof.is/claim/clm_6ACEB375E090","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"89,981,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6ACEB375E090","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2024, filed 2024-06-20"}},{"date":"2024-04-26","until":"2025-04-25","published":"2024-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 32,364,000,000 United States dollar\", as of 2024-04-26 (until 2025-04-25). Claim clm_952B9596CC77, https://asof.is/claim/clm_952B9596CC77, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000072/0001613103-24-000072-index.htm.","url":"https://asof.is/claim/clm_952B9596CC77","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"32,364,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_952B9596CC77","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2024, filed 2024-06-20"}},{"date":"2024-04-26","until":"2024-07-26","published":"2024-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,214,000,000 United States dollar\", as of 2024-04-26 (until 2024-07-26). Claim clm_B0B10CE3853B, https://asof.is/claim/clm_B0B10CE3853B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000072/0001613103-24-000072-index.htm.","url":"https://asof.is/claim/clm_B0B10CE3853B","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,214,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B0B10CE3853B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2024, filed 2024-06-20"}},{"date":"2024-04-26","until":"2025-04-25","published":"2024-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 3,676,000,000 United States dollar\", as of 2024-04-26 (until 2025-04-25). Claim clm_BF0630DE861E, https://asof.is/claim/clm_BF0630DE861E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000072/0001613103-24-000072-index.htm.","url":"https://asof.is/claim/clm_BF0630DE861E","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"3,676,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BF0630DE861E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2024-06-20"}},{"date":"2024-04-26","until":"2025-04-25","published":"2024-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 5,144,000,000 United States dollar\", as of 2024-04-26 (until 2025-04-25). Claim clm_DCA63AD2CEBA, https://asof.is/claim/clm_DCA63AD2CEBA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000072/0001613103-24-000072-index.htm.","url":"https://asof.is/claim/clm_DCA63AD2CEBA","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"5,144,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DCA63AD2CEBA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2024, filed 2024-06-20"}},{"date":"2024-06-17","until":"2024-08-22","published":"2024-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,282,269,783 shares\", as of 2024-06-17 (until 2024-08-22). Claim clm_A4A1CCDD3A31, https://asof.is/claim/clm_A4A1CCDD3A31, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000072/0001613103-24-000072-index.htm.","url":"https://asof.is/claim/clm_A4A1CCDD3A31","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,282,269,783 shares","status":"superseded","assertable":true,"id":"clm_A4A1CCDD3A31","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2024, filed 2024-06-20"}},{"date":"2024-07-26","until":"2024-10-25","published":"2024-08-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 47,947,000,000 United States dollar\", as of 2024-07-26 (until 2024-10-25). Claim clm_3D86839E9EA8, https://asof.is/claim/clm_3D86839E9EA8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000147/0001613103-24-000147-index.htm.","url":"https://asof.is/claim/clm_3D86839E9EA8","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"47,947,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3D86839E9EA8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2025, filed 2024-08-27"}},{"date":"2024-07-26","until":"2024-10-25","published":"2024-08-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,278,000,000 United States dollar\", as of 2024-07-26 (until 2024-10-25). Claim clm_7E55E13232E9, https://asof.is/claim/clm_7E55E13232E9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000147/0001613103-24-000147-index.htm.","url":"https://asof.is/claim/clm_7E55E13232E9","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,278,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7E55E13232E9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2025, filed 2024-08-27"}},{"date":"2024-07-26","until":"2024-10-25","published":"2024-08-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,915,000,000 United States dollar\", as of 2024-07-26 (until 2024-10-25). Claim clm_851341DD32FB, https://asof.is/claim/clm_851341DD32FB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000147/0001613103-24-000147-index.htm.","url":"https://asof.is/claim/clm_851341DD32FB","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"7,915,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_851341DD32FB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2025, filed 2024-08-27"}},{"date":"2024-07-26","until":"2024-10-25","published":"2024-08-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,042,000,000 United States dollar\", as of 2024-07-26 (until 2024-10-25). Claim clm_8ADDEF42124F, https://asof.is/claim/clm_8ADDEF42124F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000147/0001613103-24-000147-index.htm.","url":"https://asof.is/claim/clm_8ADDEF42124F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,042,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8ADDEF42124F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2025, filed 2024-08-27"}},{"date":"2024-07-26","until":"2024-10-25","published":"2024-08-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 89,749,000,000 United States dollar\", as of 2024-07-26 (until 2024-10-25). Claim clm_D7380CA3CE92, https://asof.is/claim/clm_D7380CA3CE92, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000147/0001613103-24-000147-index.htm.","url":"https://asof.is/claim/clm_D7380CA3CE92","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"89,749,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D7380CA3CE92","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2025, filed 2024-08-27"}},{"date":"2024-07-26","until":"2024-10-25","published":"2024-08-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,311,000,000 United States dollar\", as of 2024-07-26 (until 2024-10-25). Claim clm_E1FDBF09C8E3, https://asof.is/claim/clm_E1FDBF09C8E3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000147/0001613103-24-000147-index.htm.","url":"https://asof.is/claim/clm_E1FDBF09C8E3","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,311,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E1FDBF09C8E3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2025, filed 2024-08-27"}},{"date":"2024-08-22","until":"2024-11-20","published":"2024-08-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,282,490,493 shares\", as of 2024-08-22 (until 2024-11-20). Claim clm_7552682E7218, https://asof.is/claim/clm_7552682E7218, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000147/0001613103-24-000147-index.htm.","url":"https://asof.is/claim/clm_7552682E7218","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,282,490,493 shares","status":"superseded","assertable":true,"id":"clm_7552682E7218","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2025, filed 2024-08-27"}},{"date":"2024-10-25","until":"2025-01-24","published":"2024-11-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,270,000,000 United States dollar\", as of 2024-10-25 (until 2025-01-24). Claim clm_0A017C4E9B47, https://asof.is/claim/clm_0A017C4E9B47, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000165/0001613103-24-000165-index.htm.","url":"https://asof.is/claim/clm_0A017C4E9B47","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,270,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0A017C4E9B47","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2025, filed 2024-11-26"}},{"date":"2024-10-25","until":"2025-01-24","published":"2024-11-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,042,000,000 United States dollar\", as of 2024-10-25 (until 2025-01-24). Claim clm_1B95F96CC7F6, https://asof.is/claim/clm_1B95F96CC7F6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000165/0001613103-24-000165-index.htm.","url":"https://asof.is/claim/clm_1B95F96CC7F6","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"90,042,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1B95F96CC7F6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2025, filed 2024-11-26"}},{"date":"2024-10-25","until":"2025-01-24","published":"2024-11-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 8,403,000,000 United States dollar\", as of 2024-10-25 (until 2025-01-24). Claim clm_2A47EF57D16F, https://asof.is/claim/clm_2A47EF57D16F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000165/0001613103-24-000165-index.htm.","url":"https://asof.is/claim/clm_2A47EF57D16F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"8,403,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2A47EF57D16F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2025, filed 2024-11-26"}},{"date":"2024-10-25","until":"2025-01-24","published":"2024-11-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,394,000,000 United States dollar\", as of 2024-10-25 (until 2025-01-24). Claim clm_427852836E22, https://asof.is/claim/clm_427852836E22, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000165/0001613103-24-000165-index.htm.","url":"https://asof.is/claim/clm_427852836E22","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,394,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_427852836E22","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2025, filed 2024-11-26"}},{"date":"2024-10-25","until":"2025-01-24","published":"2024-11-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,595,000,000 United States dollar\", as of 2024-10-25 (until 2025-01-24). Claim clm_EE80D367549C, https://asof.is/claim/clm_EE80D367549C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000165/0001613103-24-000165-index.htm.","url":"https://asof.is/claim/clm_EE80D367549C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,595,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EE80D367549C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2025, filed 2024-11-26"}},{"date":"2024-10-25","until":"2025-01-24","published":"2024-11-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 48,494,000,000 United States dollar\", as of 2024-10-25 (until 2025-01-24). Claim clm_FA708EC24643, https://asof.is/claim/clm_FA708EC24643, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000165/0001613103-24-000165-index.htm.","url":"https://asof.is/claim/clm_FA708EC24643","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"48,494,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FA708EC24643","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2025, filed 2024-11-26"}},{"date":"2024-11-20","until":"2025-02-19","published":"2024-11-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,282,285,681 shares\", as of 2024-11-20 (until 2025-02-19). Claim clm_FE44128C57EF, https://asof.is/claim/clm_FE44128C57EF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000165/0001613103-24-000165-index.htm.","url":"https://asof.is/claim/clm_FE44128C57EF","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,282,285,681 shares","status":"superseded","assertable":true,"id":"clm_FE44128C57EF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2025, filed 2024-11-26"}},{"date":"2025-01-24","until":"2025-04-25","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,240,000,000 United States dollar\", as of 2025-01-24 (until 2025-04-25). Claim clm_04C48D2708F8, https://asof.is/claim/clm_04C48D2708F8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/0001613103-25-000022-index.htm.","url":"https://asof.is/claim/clm_04C48D2708F8","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,240,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_04C48D2708F8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-02-25"}},{"date":"2025-01-24","until":"2025-07-25","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,646,000,000 United States dollar\", as of 2025-01-24 (until 2025-07-25). Claim clm_2FEBB6C97128, https://asof.is/claim/clm_2FEBB6C97128, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/0001613103-25-000022-index.htm.","url":"https://asof.is/claim/clm_2FEBB6C97128","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,646,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2FEBB6C97128","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2025, filed 2025-02-25"}},{"date":"2025-01-24","until":"2025-07-25","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 8,292,000,000 United States dollar\", as of 2025-01-24 (until 2025-07-25). Claim clm_56D34613FEE0, https://asof.is/claim/clm_56D34613FEE0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/0001613103-25-000022-index.htm.","url":"https://asof.is/claim/clm_56D34613FEE0","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"8,292,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_56D34613FEE0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2025, filed 2025-02-25"}},{"date":"2025-01-24","until":"2025-04-25","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 89,973,000,000 United States dollar\", as of 2025-01-24 (until 2025-04-25). Claim clm_D4A59ACBA6DC, https://asof.is/claim/clm_D4A59ACBA6DC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/0001613103-25-000022-index.htm.","url":"https://asof.is/claim/clm_D4A59ACBA6DC","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"89,973,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D4A59ACBA6DC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-02-25"}},{"date":"2025-01-24","until":"2025-07-25","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,294,000,000 United States dollar\", as of 2025-01-24 (until 2025-07-25). Claim clm_DAC198A9262F, https://asof.is/claim/clm_DAC198A9262F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/0001613103-25-000022-index.htm.","url":"https://asof.is/claim/clm_DAC198A9262F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,294,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DAC198A9262F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-02-25"}},{"date":"2025-01-24","until":"2025-04-25","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 49,387,000,000 United States dollar\", as of 2025-01-24 (until 2025-04-25). Claim clm_E70A445E3E74, https://asof.is/claim/clm_E70A445E3E74, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/0001613103-25-000022-index.htm.","url":"https://asof.is/claim/clm_E70A445E3E74","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"49,387,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E70A445E3E74","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-02-25"}},{"date":"2025-02-19","until":"2025-06-17","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,282,543,505 shares\", as of 2025-02-19 (until 2025-06-17). Claim clm_991FE2B84ECE, https://asof.is/claim/clm_991FE2B84ECE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/0001613103-25-000022-index.htm.","url":"https://asof.is/claim/clm_991FE2B84ECE","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,282,543,505 shares","status":"superseded","assertable":true,"id":"clm_991FE2B84ECE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-02-25"}},{"date":"2025-04-25","until":"2025-07-25","published":"2025-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,218,000,000 United States dollar\", as of 2025-04-25 (until 2025-07-25). Claim clm_1E0CB0017D8B, https://asof.is/claim/clm_1E0CB0017D8B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm.","url":"https://asof.is/claim/clm_1E0CB0017D8B","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,218,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1E0CB0017D8B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2025, filed 2025-06-20"}},{"date":"2025-04-25","until":"2025-07-25","published":"2025-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 48,024,000,000 United States dollar\", as of 2025-04-25 (until 2025-07-25). Claim clm_5678A68C012F, https://asof.is/claim/clm_5678A68C012F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm.","url":"https://asof.is/claim/clm_5678A68C012F","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"48,024,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5678A68C012F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2025, filed 2025-06-20"}},{"date":"2025-04-25","until":"2025-07-25","published":"2025-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,680,000,000 United States dollar\", as of 2025-04-25 (until 2025-07-25). Claim clm_6880B626EFDC, https://asof.is/claim/clm_6880B626EFDC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm.","url":"https://asof.is/claim/clm_6880B626EFDC","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"91,680,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6880B626EFDC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2025, filed 2025-06-20"}},{"date":"2025-04-25","until":"2026-04-24","published":"2025-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 33,537,000,000 United States dollar\", as of 2025-04-25 (until 2026-04-24). Claim clm_BD95A4989472, https://asof.is/claim/clm_BD95A4989472, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm.","url":"https://asof.is/claim/clm_BD95A4989472","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"33,537,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BD95A4989472","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2025, filed 2025-06-20"}},{"date":"2025-04-25","until":"2026-04-24","published":"2025-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 4,662,000,000 United States dollar\", as of 2025-04-25 (until 2026-04-24). Claim clm_E6023C893EE6, https://asof.is/claim/clm_E6023C893EE6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm.","url":"https://asof.is/claim/clm_E6023C893EE6","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"4,662,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E6023C893EE6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2025-06-20"}},{"date":"2025-04-25","until":"2026-04-24","published":"2025-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 5,955,000,000 United States dollar\", as of 2025-04-25 (until 2026-04-24). Claim clm_F5637E2C48D0, https://asof.is/claim/clm_F5637E2C48D0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm.","url":"https://asof.is/claim/clm_F5637E2C48D0","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"5,955,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F5637E2C48D0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2025, filed 2025-06-20"}},{"date":"2025-06-17","until":"2025-08-20","published":"2025-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,281,264,703 shares\", as of 2025-06-17 (until 2025-08-20). Claim clm_D02C70FBD25B, https://asof.is/claim/clm_D02C70FBD25B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm.","url":"https://asof.is/claim/clm_D02C70FBD25B","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,281,264,703 shares","status":"superseded","assertable":true,"id":"clm_D02C70FBD25B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2025, filed 2025-06-20"}},{"date":"2025-07-25","until":"2025-10-24","published":"2025-08-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,273,000,000 United States dollar\", as of 2025-07-25 (until 2025-10-24). Claim clm_014BFE0BCD90, https://asof.is/claim/clm_014BFE0BCD90, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000161/0001613103-25-000161-index.htm.","url":"https://asof.is/claim/clm_014BFE0BCD90","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,273,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_014BFE0BCD90","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2026, filed 2025-08-26"}},{"date":"2025-07-25","until":"2025-10-24","published":"2025-08-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,040,000,000 United States dollar\", as of 2025-07-25 (until 2025-10-24). Claim clm_057F0CBD33FC, https://asof.is/claim/clm_057F0CBD33FC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000161/0001613103-25-000161-index.htm.","url":"https://asof.is/claim/clm_057F0CBD33FC","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,040,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_057F0CBD33FC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2026, filed 2025-08-26"}},{"date":"2025-07-25","until":"2025-10-24","published":"2025-08-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,445,000,000 United States dollar\", as of 2025-07-25 (until 2025-10-24). Claim clm_4CFFD5044F09, https://asof.is/claim/clm_4CFFD5044F09, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000161/0001613103-25-000161-index.htm.","url":"https://asof.is/claim/clm_4CFFD5044F09","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,445,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4CFFD5044F09","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2026, filed 2025-08-26"}},{"date":"2025-07-25","until":"2025-10-24","published":"2025-08-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 8,578,000,000 United States dollar\", as of 2025-07-25 (until 2025-10-24). Claim clm_5C2762F7EEA3, https://asof.is/claim/clm_5C2762F7EEA3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000161/0001613103-25-000161-index.htm.","url":"https://asof.is/claim/clm_5C2762F7EEA3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"8,578,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5C2762F7EEA3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2026, filed 2025-08-26"}},{"date":"2025-07-25","until":"2025-10-24","published":"2025-08-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 47,893,000,000 United States dollar\", as of 2025-07-25 (until 2025-10-24). Claim clm_5EED07B34D7D, https://asof.is/claim/clm_5EED07B34D7D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000161/0001613103-25-000161-index.htm.","url":"https://asof.is/claim/clm_5EED07B34D7D","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"47,893,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5EED07B34D7D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2026, filed 2025-08-26"}},{"date":"2025-07-25","until":"2025-10-24","published":"2025-08-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,972,000,000 United States dollar\", as of 2025-07-25 (until 2025-10-24). Claim clm_FCCA2A3973FC, https://asof.is/claim/clm_FCCA2A3973FC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000161/0001613103-25-000161-index.htm.","url":"https://asof.is/claim/clm_FCCA2A3973FC","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"90,972,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FCCA2A3973FC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2026, filed 2025-08-26"}},{"date":"2025-08-20","until":"2025-11-19","published":"2025-08-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,282,685,882 shares\", as of 2025-08-20 (until 2025-11-19). Claim clm_87B312F89145, https://asof.is/claim/clm_87B312F89145, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000161/0001613103-25-000161-index.htm.","url":"https://asof.is/claim/clm_87B312F89145","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,282,685,882 shares","status":"superseded","assertable":true,"id":"clm_87B312F89145","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2026, filed 2025-08-26"}},{"date":"2025-10-24","until":"2026-01-23","published":"2025-11-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,374,000,000 United States dollar\", as of 2025-10-24 (until 2026-01-23). Claim clm_118045E4DEEB, https://asof.is/claim/clm_118045E4DEEB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828025053988/0001628280-25-053988-index.htm.","url":"https://asof.is/claim/clm_118045E4DEEB","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,374,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_118045E4DEEB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2026, filed 2025-11-25"}},{"date":"2025-10-24","until":"2026-01-23","published":"2025-11-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 48,652,000,000 United States dollar\", as of 2025-10-24 (until 2026-01-23). Claim clm_4F04018ED36E, https://asof.is/claim/clm_4F04018ED36E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828025053988/0001628280-25-053988-index.htm.","url":"https://asof.is/claim/clm_4F04018ED36E","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"48,652,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4F04018ED36E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2026, filed 2025-11-25"}},{"date":"2025-10-24","until":"2026-01-23","published":"2025-11-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,346,000,000 United States dollar\", as of 2025-10-24 (until 2026-01-23). Claim clm_9525D576D532, https://asof.is/claim/clm_9525D576D532, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828025053988/0001628280-25-053988-index.htm.","url":"https://asof.is/claim/clm_9525D576D532","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"91,346,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9525D576D532","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2026, filed 2025-11-25"}},{"date":"2025-10-24","until":"2026-01-23","published":"2025-11-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 8,961,000,000 United States dollar\", as of 2025-10-24 (until 2026-01-23). Claim clm_AA279C6B64A0, https://asof.is/claim/clm_AA279C6B64A0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828025053988/0001628280-25-053988-index.htm.","url":"https://asof.is/claim/clm_AA279C6B64A0","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"8,961,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AA279C6B64A0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2026, filed 2025-11-25"}},{"date":"2025-10-24","until":"2026-01-23","published":"2025-11-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,686,000,000 United States dollar\", as of 2025-10-24 (until 2026-01-23). Claim clm_BFF6E998E45F, https://asof.is/claim/clm_BFF6E998E45F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828025053988/0001628280-25-053988-index.htm.","url":"https://asof.is/claim/clm_BFF6E998E45F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,686,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BFF6E998E45F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2026, filed 2025-11-25"}},{"date":"2025-10-24","until":"2026-01-23","published":"2025-11-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,282,000,000 United States dollar\", as of 2025-10-24 (until 2026-01-23). Claim clm_C7B7213C07A8, https://asof.is/claim/clm_C7B7213C07A8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828025053988/0001628280-25-053988-index.htm.","url":"https://asof.is/claim/clm_C7B7213C07A8","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,282,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C7B7213C07A8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2026, filed 2025-11-25"}},{"date":"2025-11-19","until":"2026-02-18","published":"2025-11-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,282,014,208 shares\", as of 2025-11-19 (until 2026-02-18). Claim clm_140F0E7AF0B7, https://asof.is/claim/clm_140F0E7AF0B7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828025053988/0001628280-25-053988-index.htm.","url":"https://asof.is/claim/clm_140F0E7AF0B7","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,282,014,208 shares","status":"superseded","assertable":true,"id":"clm_140F0E7AF0B7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2026, filed 2025-11-25"}},{"date":"2026-01-23","until":"2026-04-24","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 48,985,000,000 United States dollar\", as of 2026-01-23 (until 2026-04-24). Claim clm_28AC66A9C742, https://asof.is/claim/clm_28AC66A9C742, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/0001628280-26-011107-index.htm.","url":"https://asof.is/claim/clm_28AC66A9C742","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"48,985,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_28AC66A9C742","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-02-24"}},{"date":"2026-01-23","until":"2026-07-31","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,143,000,000 United States dollar\", as of 2026-01-23 (until 2026-07-31). Claim clm_3D23FE7B2346, https://asof.is/claim/clm_3D23FE7B2346, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/0001628280-26-011107-index.htm.","url":"https://asof.is/claim/clm_3D23FE7B2346","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,143,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3D23FE7B2346","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-02-24"}},{"date":"2026-01-23","until":"2026-07-31","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 9,017,000,000 United States dollar\", as of 2026-01-23 (until 2026-07-31). Claim clm_3D738F205AB6, https://asof.is/claim/clm_3D738F205AB6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/0001628280-26-011107-index.htm.","url":"https://asof.is/claim/clm_3D738F205AB6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"9,017,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3D738F205AB6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2026, filed 2026-02-24"}},{"date":"2026-01-23","until":"2026-07-31","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,464,000,000 United States dollar\", as of 2026-01-23 (until 2026-07-31). Claim clm_6B05B9ABD791, https://asof.is/claim/clm_6B05B9ABD791, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/0001628280-26-011107-index.htm.","url":"https://asof.is/claim/clm_6B05B9ABD791","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,464,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6B05B9ABD791","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2026, filed 2026-02-24"}},{"date":"2026-01-23","until":"2026-04-24","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,147,000,000 United States dollar\", as of 2026-01-23 (until 2026-04-24). Claim clm_BE1FF64F012F, https://asof.is/claim/clm_BE1FF64F012F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/0001628280-26-011107-index.htm.","url":"https://asof.is/claim/clm_BE1FF64F012F","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,147,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BE1FF64F012F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-02-24"}},{"date":"2026-01-23","until":"2026-04-24","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,485,000,000 United States dollar\", as of 2026-01-23 (until 2026-04-24). Claim clm_C2D96E5638A1, https://asof.is/claim/clm_C2D96E5638A1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/0001628280-26-011107-index.htm.","url":"https://asof.is/claim/clm_C2D96E5638A1","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"91,485,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C2D96E5638A1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-02-24"}},{"date":"2026-02-18","until":"2026-06-12","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,283,884,964 shares\", as of 2026-02-18 (until 2026-06-12). Claim clm_3A995D7DDA51, https://asof.is/claim/clm_3A995D7DDA51, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/0001628280-26-011107-index.htm.","url":"https://asof.is/claim/clm_3A995D7DDA51","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,283,884,964 shares","status":"superseded","assertable":true,"id":"clm_3A995D7DDA51","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-02-24"}},{"date":"2026-04-24","until":null,"published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 36,364,000,000 United States dollar\", as of 2026-04-24. Claim clm_415097FA3412, https://asof.is/claim/clm_415097FA3412, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm.","url":"https://asof.is/claim/clm_415097FA3412","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"36,364,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_415097FA3412","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2026, filed 2026-06-18"}},{"date":"2026-04-24","until":"2026-07-31","published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 49,463,000,000 United States dollar\", as of 2026-04-24 (until 2026-07-31). Claim clm_837519048D94, https://asof.is/claim/clm_837519048D94, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm.","url":"https://asof.is/claim/clm_837519048D94","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"49,463,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_837519048D94","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2026, filed 2026-06-18"}},{"date":"2026-04-24","until":"2026-07-31","published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 93,028,000,000 United States dollar\", as of 2026-04-24 (until 2026-07-31). Claim clm_8727C002D5B4, https://asof.is/claim/clm_8727C002D5B4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm.","url":"https://asof.is/claim/clm_8727C002D5B4","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"93,028,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8727C002D5B4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2026, filed 2026-06-18"}},{"date":"2026-04-24","until":null,"published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 4,801,000,000 United States dollar\", as of 2026-04-24. Claim clm_92CDD59F4653, https://asof.is/claim/clm_92CDD59F4653, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm.","url":"https://asof.is/claim/clm_92CDD59F4653","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"4,801,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_92CDD59F4653","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2026, filed 2026-06-18"}},{"date":"2026-04-24","until":null,"published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 6,467,000,000 United States dollar\", as of 2026-04-24. Claim clm_997A28ACE0D9, https://asof.is/claim/clm_997A28ACE0D9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm.","url":"https://asof.is/claim/clm_997A28ACE0D9","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"6,467,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_997A28ACE0D9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2026, filed 2026-06-18"}},{"date":"2026-04-24","until":"2026-07-31","published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,949,000,000 United States dollar\", as of 2026-04-24 (until 2026-07-31). Claim clm_F5EE13882810, https://asof.is/claim/clm_F5EE13882810, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm.","url":"https://asof.is/claim/clm_F5EE13882810","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,949,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F5EE13882810","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2026, filed 2026-06-18"}},{"date":"2026-06-12","until":"2026-08-28","published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,280,045,190 shares\", as of 2026-06-12 (until 2026-08-28). Claim clm_7C472EEBBBE0, https://asof.is/claim/clm_7C472EEBBBE0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm.","url":"https://asof.is/claim/clm_7C472EEBBBE0","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,280,045,190 shares","status":"superseded","assertable":true,"id":"clm_7C472EEBBBE0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2026, filed 2026-06-18"}},{"date":"2026-07-31","until":null,"published":"2026-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,691,000,000 United States dollar\", as of 2026-07-31. Claim clm_2CD52B076B03, https://asof.is/claim/clm_2CD52B076B03, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm.","url":"https://asof.is/claim/clm_2CD52B076B03","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,691,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_2CD52B076B03","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2027, filed 2026-09-03"}},{"date":"2026-07-31","until":null,"published":"2026-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,232,000,000 United States dollar\", as of 2026-07-31. Claim clm_48244293F242, https://asof.is/claim/clm_48244293F242, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm.","url":"https://asof.is/claim/clm_48244293F242","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,232,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_48244293F242","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2027, filed 2026-09-03"}},{"date":"2026-07-31","until":null,"published":"2026-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 9,756,000,000 United States dollar\", as of 2026-07-31. Claim clm_91F66AE959A1, https://asof.is/claim/clm_91F66AE959A1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm.","url":"https://asof.is/claim/clm_91F66AE959A1","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"9,756,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_91F66AE959A1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2027, filed 2026-09-03"}},{"date":"2026-07-31","until":null,"published":"2026-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 93,306,000,000 United States dollar\", as of 2026-07-31. Claim clm_92076A104DAA, https://asof.is/claim/clm_92076A104DAA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm.","url":"https://asof.is/claim/clm_92076A104DAA","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"93,306,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_92076A104DAA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2027, filed 2026-09-03"}},{"date":"2026-07-31","until":null,"published":"2026-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,470,000,000 United States dollar\", as of 2026-07-31. Claim clm_9AE008BCBEB5, https://asof.is/claim/clm_9AE008BCBEB5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm.","url":"https://asof.is/claim/clm_9AE008BCBEB5","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,470,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_9AE008BCBEB5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2027, filed 2026-09-03"}},{"date":"2026-07-31","until":null,"published":"2026-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,764,000,000 United States dollar\", as of 2026-07-31. Claim clm_9DA82C15819F, https://asof.is/claim/clm_9DA82C15819F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm.","url":"https://asof.is/claim/clm_9DA82C15819F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,764,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_9DA82C15819F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2027, filed 2026-09-03"}},{"date":"2026-08-28","until":null,"published":"2026-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,279,137,890 shares\", as of 2026-08-28. Claim clm_CBEA1FF4A351, https://asof.is/claim/clm_CBEA1FF4A351, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm.","url":"https://asof.is/claim/clm_CBEA1FF4A351","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,279,137,890 shares","status":"valid","assertable":true,"id":"clm_CBEA1FF4A351","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2027, filed 2026-09-03"}}],"complete":true,"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"low_confidence":"Confidence below 0.5, the line the record asserts at.","not_held":"Did not hold on the date asked (for a claim's own dates: it ended the day it began)."},"checked_by":{"sec-filing":"parsed from the SEC filing","own-site":"the entity's own site names it (a website whose page names the entity, a handle its website links to)","page-read":"its source page states the value and the date"}}}